Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

Search
Advanced Search
OPEN ACCESS
mobile search button mobile menu button

Articles

Page Path
HOME > Cancer Res Treat > Volume 52(2); 2020 > Article
Special Article Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017
Seri Hong, MD, PhD1,2, Young-Joo Won, PhD1,2,3,, Young Ran Park, MS1,2, Kyu-Won Jung, MS1,2, Hyun-Joo Kong, MS1,2, Eun Sook Lee, MD, PhD1,4, The Community of Population-Based Regional Cancer Registries*,*
Cancer Research and Treatment : Official Journal of Korean Cancer Association 2020;52(2):335-350.
DOI: https://doi.org/10.4143/crt.2020.206
Published online: March 16, 2020

1Korea Central Cancer Registry, National Cancer Center, Goyang, Korea

2Division of Cancer Registration and Surveillance, National Cancer Control Institute, National Cancer Center, Goyang, Korea

3Department of Cancer Control and Population Health, National Cancer Center Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea

4National Cancer Center Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea

Correspondence: Young-Joo Won, PhD Korea Central Cancer Registry, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 10408, Korea
Tel: 82-31-920-2015 Fax: 82-31-920-2179 E-mail: astra67@ncc.re.kr
• Received: March 10, 2020   • Accepted: March 15, 2020

Copyright © 2020 by the Korean Cancer Association

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 28,471 Views
  • 1,126 Download
  • 303 Web of Science
  • 336 Crossref
  • 320 Scopus
next
Full Article

Download PDF Download PDF

  • Purpose
    This study reports the cancer statistics and temporal trends in Korea on a nationwide scale, including incidence, survival, prevalence, and mortality in 2017.
  • Materials and Methods
    The incidence, survival, and prevalence rates of cancer were evaluated using data from the Korea National Cancer Incidence Database from 1999 to 2017 with follow-up until December 31, 2018. Deaths from cancer were assessed using cause-of-death data from 1983 to 2017, obtained from Statistics Korea. Crude and age-standardized rates (ASRs) for incidence, mortality, and prevalence, and 5-year relative survival rates were calculated and trend analysis was performed.
  • Results
    In 2017, newly diagnosed cancer cases and deaths from cancer numbered 232,255 (ASR, 264.4 per 100,000) and 78,863 (ASR, 76.6 per 100,000), respectively. The overall cancer incidence rates increased annually by 3.5% from 1999 to 2011 and decreased by 2.7% annually thereafter. Cancer mortality rates have been decreasing since 2002, by 2.8% annually. The 5-year relative survival rate for all patients diagnosed with cancer between 2013 and 2017 was 70.4%, which contributed to a prevalence of approximately 1.87 million cases by the end of 2017.
  • Conclusion
    The burden of cancer measured by incidence and mortality rates have improved in Korea, with the exception of a few particular cancers that are associated with increasing incidence or mortality rates. However, cancer prevalence is increasing rapidly, with the dramatic improvement in survival during the past several years. Comprehensive cancer control strategies and efforts should continue, based on the changes of cancer statistics.
  • Key words: Incidence, Survival, Prevalence, Mortality, Neoplasms, Korea
Recent studies on global burden of disease have revealed the huge burden imposed by cancer worldwide [1], and in contrast with the improvements detected for other non-communicable diseases, a worsening trend for cancer burden has been identified [2]. To precisely evaluate the cancer burden and to appropriately manage cancer control plans or strategies at the level of nations, monitoring cancer statistics is of the utmost importance. In Korea, cancer is the leading cause of death, and the number of new cases increases each year [3]. This study reports the most recent nationwide statistics on cancer incidence, survival, prevalence, and mortality, and their temporal trends.
1. Data sources
The Korea National Cancer Incidence Database (KNCI DB) is a national, population-based database of cancer occurrence that includes information on patients diagnosed with cancer in hospitals across Korea and combined this with data provided by central and 11 regional cancer registries which included information regarding missing cancer patients; all this took 2 years to compile. Data from this database is used to examine cancer incidence, 5-year relative survival, and prevalence rates. The Korea Central Cancer Registry (KCCR) has compiled KNCI DB, and reported related nationwide statistics from 1999 onward. Detailed information on the KCCR and KNCI DB is provided elsewhere [3,4]. Completeness is an important indicator of data quality, and the 2017 KNCI DB was estimated to be 98.2% complete using the method proposed by Ajiki et al. [5].
Mortality data including cause of death and mid-year population data from 1983 to 2017 were obtained from Statistics Korea [6]. To verify the accuracy of individual vital statuses when calculating survival and prevalence rates, the KNCI DB was linked to both mortality data and population resident registration data, which were obtained from the Ministry of the Interior and Safety.
2. Cancer classification
All cancer cases had been registered in accordance with the International Classification of Diseases for Oncology, 3rd edition (ICD-O-3) [7], and were converted to the classification of the International Classification of Diseases, 10th edition (ICD-10) [8]. Only cases defined as malignant under the ICD-O-3 were included, with the exception of some hematopoietic diseases (myeloproliferative disorders/myelodysplastic syndromes). For mortality data, causes of death were coded according to the ICD-10. We classified cancers into 24 types, using a modified classification based on the taxonomy of 61 cancers used in Cancer Incidence in Five Continents, published by the International Association of Cancer Registries [9]. The summary staging system developed under the Surveillance, Epidemiology, and End Results (SEER) program (i.e., SEER summary staging) [10], was used to categorize the extent of tumor invasion or metastasis.
3. Statistical analyses
Incidence, mortality, and prevalence rates were expressed as crude rates (CRs) or age-standardized rates (ASRs) per 100,000 people. The CR was defined as the total number of newly diagnosed (for incidence) or deceased (for mortality) cases in a year divided by the mid-year population. The ASR, a weighted average of the age-specific rates in which the weights represent the proportions of people in the corresponding age groups in a standard population [11], was calculated to compare rates across different countries, regions, or time periods with different population age structures. ASRs were standardized using Segi’s world standard population [12]. The lifetime probabilities of developing cancer were assessed as cumulative cancer risks from birth to life expectancy, assuming no other cause of death (i.e., the sum of the age-specific rates from birth to life expectancy), as follows [11]:
Cumulative risk of developing cancer from birth to life expectancy=100×(1-e-cumulative rate100)
Trends in ASRs were estimated using Joinpoint regression [13], and the results were summarized as an annual percentage change using a linear model on the natural log-transformed ASRs.
The 5-year relative survival rates, defined as the ratio of observed survival of cancer patients to expected survival in the general population, were adjusted for the effects of other causes of death using the standard population life table provided by Statistics Korea [6]. Survival rates in this report, including previously published rates, were calculated using the newly updated life table. Relative survival rates were estimated using the Ederer II method [14] with some minor corrections, based on an algorithm devised by Paul Dickman [15]. Trends in 5-year relative survival rates were evaluated as percent differences in survival rates between 1993-1995 and 2013-2017.
Prevalent cases were defined as the number of cancer patients alive on January 1, 2018 among all patients diagnosed with cancer between 1999 and 2017. Limited-duration prevalence was calculated using SEER*Stat 8.1.2 software (National Cancer Institute, Bethesda, MD). p < 0.05 was considered statistically significant. SEER*Stat, Joinpoint 4.7.0 (National Cancer Institute), and SAS ver. 9.4 (SAS Institute Inc., Cary, NC) were used for statistical analysis.
1. Incidence
In 2017, there were 232,255 newly diagnosed cancer cases in Korea, of which 122,292 (52.7%) were reported in men and 109,963 (47.3%) were reported in women (Table 1). Stomach, colorectal, and lung cancers were commonly diagnosed in both sexes; these were followed by prostate cancer and liver cancer in men, whereas breast cancer and thyroid cancer were more commonly diagnosed in women. Collectively, the five most common cancers in men and women accounted for 65.0% and 65.5% of all cancer cases, respectively. Table 2 presents the CRs and ASRs of overall incidence and incidence of each cancer in 2017. The ASR of thyroid cancer, which occurs relatively frequently in younger age groups, was the highest. The overall lifetime probability of being diagnosed with any cancer was 37.0%, if one survives to reach the age that matches the life expectancy of the Korean population. That probability was higher in men (39.6%) than in women (33.8%) (data not shown).
In terms of age-specific incidence rates, leukemia (0-14 years) and thyroid cancer (15-34 years) were the most common cancers in both sexes among the childhood and ‘adolescent and young adult’ populations (Fig. 1). Brain and central nervous system (CNS) cancer and non-Hodgkin lymphoma were ranked next in the 0-14-year age group (both sexes), while breast cancer (women) and leukemia (men) were the next highest in terms of incidence in the 15-34-year age group. In the 35-64-year age group, men were most commonly diagnosed with stomach cancer and colorectal cancer, while breast cancer and thyroid cancer were most common in women. For those aged 65 years and above, lung cancer and stomach cancer were most common in men, while colorectal cancer and lung cancer were most common in women. The incidence rates of all major cancers increased with age; therefore, cases diagnosed at over 60 years accounted for the majority of incidences (Fig. 2). The only exceptions to this were the incidences of thyroid and breast cancer in women, which were the highest in women in their 40s and 50s.
2. Mortality
A total of 78,863 people (62.0% men and 38.0% women) died of cancer in 2017, accounting for 27.6% of all deaths ccurring in Korea (Tables 1 and 3). The overall CR for cancer deaths was 153.9 per 100,000, and the cancer mortality rate was higher in men than in women (Table 4). The top five cancers in terms of mortality rates were lung, liver, colorectal, stomach, and pancreatic cancers. Lung cancer was the leading cause of death in both sexes, followed by liver cancer and stomach cancer in men, and colorectal cancer and stomach cancer in women. When stratified based on age at time of death, the most common causes of cancer mortality were as follows: leukemia at ages 10 and 20 years, stomach cancer at 30 years, liver cancer at 40 and 50 years, and lung cancer at 60 years or more (data not shown).
3. Trends in cancer incidence and mortality
Fig. 3 illustrates the trends in cancer incidence rates from 1999 to 2017 and mortality rates from 1983 to 2017. The overall cancer incidence rates increased by approximately 3.5% per year until 2011, and thereafter declined by approximately 2.7% per year (Table 5). These trends were observed in both men and women, although the slopes of change were much more pronounced in women. Breast, prostate, kidney, and pancreatic cancer incidences have been continuously increasing since 1999; showing a steady increase for pancreatic cancer throughout the entire period, while the rest of those cancers revealed initially displaying rapid increases and then moderate increases after 2002 or 2009. The incidences of colorectal cancer, thyroid cancer, and bladder cancer demonstrated increasing trends that have recently reversed significantly, with decreases starting in 2010, 2011, and 2004, respectively. The rapid increase and decrease in the incidence of thyroid cancer ASRs were similar to overall trend of cancer incidence (i.e., the timing and pattern of changes), appears that the former has a major influence on the latter. In contrast, stomach, liver, and cervical cancers have displayed steady decreases in incidence since 1999 (Fig. 4).
The ASRs for the mortality of all cancers increased until 2002, then continuously decreased thereafter (Table 6, Fig. 3). More rapid changes were observed in decreasing phase compared to the preceding increasing phase, and the slopes of change were much more pronounced in men than in women. Continuous decreasing trends were evident throughout the observed period for mortality associated with stomach, liver, and uterine cancer, whereas the mortality rates associated with colorectal cancer and lung cancer (men) began to decline in the early or mid-2000s, after an initial increasing trend. Prostate cancer and breast cancer (women) displayed steadily increasing mortality trends; however, attenuation of the increasing trend in prostate cancer has been observed in recent years (Fig. 5).
4. Survival rates
The 5-year relative survival rates for all patients diagnosed with cancer in the recent 5 years, from 2013 to 2017 were 63.5% in men and 77.5% in women, for a combined overall survival rate of 70.4% (Table 7). The temporal trends in survival rates demonstrated remarkable improvement in both sexes, from 42.9% in 1993-1995 to 70.4% in 2013-2017. Such findings were maintained even after excluding thyroid cancer, which has excellent prognosis and a 5-year relative survival rate of 100.1%.
After thyroid cancer, survival was the highest for prostate and testicular cancers in men (94.1% and 95.2%, respectively) and for breast cancer in women (93.2%); the survival was lowest for cancers of the pancreas (12.2%), gallbladder plus other and unspecified parts of the biliary tract (28.9%), lung (30.2%), and liver (35.6%). Stomach cancer (both sexes), prostate cancer (men), and lung cancer (women) were associated with outstanding improvements in survival rate over the time period studied. In contrast, advances have been slow for pancreatic cancer, as well as cancers of the brain and CNS.
Fig. 6 shows the 5-year relative survival rates (2013-2017) based on SEER summary stage and stage distribution at diagnosis of the top 10 most common cancers for each sex in 2017. In men, 63.9%, 71.3%, and 73.1% of the stomach, kidney, and bladder cancers, respectively, were diagnosed at the localized stage, with 5-year survival rates of 97.4%, 97.5%, and 87.9%, respectively. However, these rates decreased to 6.0% (10.9% of cases), 13.9% (12.3% of cases), and 9.4% (4.0% of cases), respectively, for cases diagnosed at the distant metastatic stage. In women, 58.1%, 61.9%, and 71.5% of the breast, stomach, and uterine corpus cancers, respectively, were diagnosed at the localized stage, with 5-year survival rates of 98.7%, 95.3%, and 95.7%, respectively. These rates decreased to 39.9% (4.8% of cases), 4.9% (10.8% of cases), and 32.6% (6.9% of cases), respectively, for cases diagnosed at the distant metastatic stage. In both sexes, relatively large proportions (> 40%) of lung and pancreatic cancers were diagnosed at the distant metastatic stage, resulting in poor prognosis.
5. Prevalence rates
A total of 1,867,405 cancer cases were identified as of January 1, 2018 (Table 1), suggesting that 1 in 28 people, i.e., 3.6% of the Korean population (3.2% of men and 4.1% of women) has a history of being diagnosed with cancer. Of these, 826,103 (44.2% of all prevalent cases) were aged ≥ 65 years, indicating that 1 in 9 people in that age group (15.2% of men and 9.1% of women) will have experienced cancer (data not shown).
Table 8 presents the CRs and ASRs of prevalence for all cancers combined and for specific cancers. In the total population, thyroid cancer had the highest prevalence (CR, 790.6 per 100,000, derived from 277.7 per 100,000 for men and 1,302.0 per 100,000 for women), followed by stomach cancer (CR, 564.6 per 100,000) and colorectal cancer (CR, 490.1 per 100,000). Prostate cancer and breast cancer (women) also revealed high prevalence rates (CR, 337.9 and 843.5 per 100,000, respectively).
Fig. 7 depicts the number of prevalent cases for common cancers, categorized according to time since cancer diagnosis. In total, 1,039,659 (55.7% of all prevalent cases) had survived > 5 years after cancer diagnosis, including high proportion of patients diagnosed with thyroid, stomach, colorectal, breast, and cervical cancers. Another 446,428 (23.9% of all prevalent cases) were alive 2-5 years after their cancer diagnosis, leaving 381,318 (20.4% of all prevalent cases) who had been diagnosed for < 2 years and who may still be undergoing active cancer treatment.
In summary, the numbers of newly diagnosed cancer cases and cancer-related deaths in 2017 were 232,255 and 78,863, respectively. Although overall cancer incidence and mortality have declined since 2011 and 2002, respectively, some cancers, such as breast and prostate cancer, demonstrate increasing trends with respect to both incidence and mortality. The 5-year relative survival rates have continuously improved, reaching 70.4% for all patients diagnosed with cancer between 2013 and 2017. Accordingly, cancer prevalence continues to increase, reaching approximately 1.87 million by the end of 2017. Although overall cancer incidence and mortality rates are on decreasing trend in Korea, improved survival is rapidly increasing cancer prevalence. These results suggest that comprehensive cancer control strategies and efforts should continue, based on the changes of cancer statistics.

Conflict of interest relevant to this article was not reported.

Acknowledgements
Special thanks to the tumor registrars (health information managers) of the Korea Central Cancer Registry (KCCR)-affiliated and non-KCCR-affiliated hospitals for data collection, abstracting, and coding. Additionally, we acknowledge the cooperation of the National Health Insurance Service and Statistics Korea for data support. This work was supported by the Health Promotion Fund of the Ministry of Health & Welfare (No. 1960530) and a research grant (No. 1910130) from the National Cancer Center, Republic of Korea.

Regional Cancer Registry Committee

Chang-Hoon Kim (Busan Cancer Registry, Pusan National University Hospital), Cheol-In Yoo (Ulsan Caner Registry, Ulsan University Hospital), Yong-Dae Kim (Chungbuk Cancer Registry, Chungbuk National University Hospital), Hae-Sung Nam (Daejeon/Chungnam Cancer Registry, Chungnam National University and Hospital), Jung-Sik Huh (Jeju Cancer Registry, Jeju National University and Hospital), Jung-Ho Youm (Chonbuk Cancer Registry, Jeonbuk National University Hospital), Kyuhyoung Lim (Kangwon Cancer Registry, Kangwon National University Hospital), Nam-Soo Hong (Deagu/Gyeongbuk Cancer Registry, Kyungpook National University Medical Center), Sun-Seog Kweon (Gwangju/Jeonnam Cancer Registry, Chonnam National University Hwasun Hospital), Woo-Chul Kim (Incheon Cancer Registry, Inha University Hospital), Ki-Soo Park (Gyeongnam Cancer Registry, Gyeongsang National University and Hospital)

Fig. 1.
The five common sites of cancer incidence by age group and sex for 2017 in Korea. (A) Men. (B) Women. Numbers on each section are age-specific incidence rates per 100,000. CNS, central nervous system. a)Includes the gallbladder and other/unspecified parts of the biliary tract.
crt-2020-206f1.jpg
Fig. 2.
Age-specific incidence rates of common cancers for 2017 in Korea. (A) Men. (B) Women.
crt-2020-206f2.jpg
Fig. 3.
Annual age-standardized cancer incidence and mortality rates by sex for all sites from 1983 to 2017 in Korea. Age standardization was based on Segi’s world standard population.
crt-2020-206f3.jpg
Fig. 4.
Trends in age-standardized incidences of selected cancers by sex from 1999 to 2017 in Korea. (A) Men. (B) Women. Age standardization was based on Segi’s world standard population.
crt-2020-206f4.jpg
Fig. 5.
Trends in age-standardized mortalities of selected cancers by sex from 1983 to 2017 in Korea. (A) Men. (B) Women. Age standardization was based on Segi’s world standard population. a)Cancers of cervix uteri, corpus uteri, and unspecified parts of the uterus were combined (C53-C55), due to their unclear classifications in the past.
crt-2020-206f5.jpg
Fig. 6.
Five-year relative survival rates by stage at diagnosis and stage distribution of selected cancers by sex in Korea, 2013-2017. (A) Men. (B) Women. Staging according to the Surveillance, Epidemiology, and End Results (SEER) stage categories. For each cancer type, stage categories do not total 100% because sufficient information was not available to stage all cases. a)Includes the gallbladder and other/unspecified parts of the biliary tract.
crt-2020-206f6.jpg
Fig. 7.
Prevalent cases of common cancers by time since cancer diagnosis. Prevalent cases were defined as the number of cancer patients alive on January 1, 2018 among all cancer patients diagnosed between 1999 and 2017.
crt-2020-206f7.jpg
Table 1.
Cancer incidence, deaths, and prevalence by sex in Korea, 2017
Site/Type New cases
 Deaths
 Prevalent casesa)
Both sexes Men Women Both sexes Men Women Both sexes Men Women
All sites 232,255 122,292 109,963 78,863 48,866 29,997 1,867,405 819,838 1,047,567
Lip, oral cavity, and pharynx 3,667 2,625 1,042 1,199 928 271 25,450 17,007 8,443
Esophagus 2,483 2,239 244 1,423 1,290 133 10,403 9,319 1,084
Stomach 29,685 19,916 9,769 8,034 5,166 2,868 289,223 191,389 97,834
Colon and rectum 28,111 16,653 11,458 8,691 4,981 3,710 251,063 149,310 101,753
Liverb) 15,405 11,500 3,905 10,721 7,982 2,739 68,077 51,068 17,009
Gallbladderc) 6,846 3,555 3,291 4,717 2,392 2,325 22,375 11,479 10,896
Pancreas 7,032 3,733 3,299 5,782 2,976 2,806 11,776 6,172 5,604
Larynx 1,218 1,142 76 372 349 23 10,990 10,334 656
Lungd) 26,985 18,657 8,328 17,980 13,272 4,708 84,242 51,808 32,434
Breast 22,395 95 22,300 2,517 20 2,497 217,203 801 216,402
Cervix uteri 3,469 - 3,469 868 - 868 54,914 - 54,914
Corpus uteri 2,986 - 2,986 320 - 320 25,590 - 25,590
Ovary 2,702 - 2,702 1,149 - 1,149 21,013 - 21,013
Prostate 12,797 12,797 - 1,821 1,821 - 86,435 86,435 -
Testis 262 262 - 15 15 - 3,441 3,441 -
Kidney 5,299 3,617 1,682 1,000 687 313 42,513 28,611 13,902
Bladder 4,379 3,525 854 1,438 1,100 338 35,585 29,024 6,561
Brain and CNS 1,947 1,036 911 1,319 738 581 11,719 5,998 5,721
Thyroid 26,170 6,035 20,135 369 111 258 405,032 71,015 334,017
Hodgkin lymphoma 287 172 115 55 43 12 3,004 1,871 1,133
Non-Hodgkin lymphoma 4,762 2,708 2,054 1,786 997 789 32,519 18,475 14,044
Multiple myeloma 1,629 857 772 964 512 452 6,375 3,339 3,036
Leukemia 3,366 1,916 1,450 1,834 1,042 792 22,218 12,369 9,849
Other and ill-defined 18,373 9,252 9,121 4,489 2,444 2,045 126,245 60,573 65,672

CNS, central nervous system.

a) Limited-duration prevalent cases on January 1, 2017. These are patients who were diagnosed between January 1, 1999 and December 31, 2017, and who were alive on January 1, 2018. Multiple primary cancer cases were counted multiple times,

b) Includes the liver and intrahepatic bile duct,

c) Includes the gallbladder and other/unspecified parts of the biliary tract,

d) Includes the lung and bronchus.

Table 2.
Crude and age-standardized cancer incidence rates by sex in Korea, 2017
Site/Type Crude incidence rate per 100,000
 Age-standardized incidence rate per 100,000a)
Both sexes Men Women Both sexes Men Women
All sites 453.4 478.1 428.6 264.4 291.3 251.5
Lip, oral cavity, and pharynx 7.2 10.3 4.1 4.3 6.3 2.4
Esophagus 4.8 8.8 1.0 2.6 5.1 0.5
Stomach 57.9 77.9 38.1 32.0 46.4 19.6
Colon and rectum 54.9 65.1 44.7 29.7 38.8 21.8
Liverb) 30.1 45.0 15.2 16.5 26.8 7.2
Gallbladderc) 13.4 13.9 12.8 6.6 8.0 5.5
Pancreas 13.7 14.6 12.9 7.1 8.5 5.8
Larynx 2.4 4.5 0.3 1.3 2.6 0.1
Lungd) 52.7 72.9 32.5 27.1 42.1 15.5
Breast 43.7 0.4 86.9 28.0 0.2 55.6
Cervix uteri 6.8 - 13.5 4.4 - 8.7
Corpus uteri 5.8 - 11.6 3.7 - 7.3
Ovary 5.3 - 10.5 3.4 - 6.8
Prostate 25.0 50.0 - 12.9 28.9 -
Testis 0.5 1.0 - 0.5 1.0 -
Kidney 10.3 14.1 6.6 6.3 8.9 3.8
Bladder 8.5 13.8 3.3 4.3 8.0 1.5
Brain and CNS 3.8 4.1 3.6 2.9 3.1 2.7
Thyroid 51.1 23.6 78.5 36.8 17.0 57.2
Hodgkin lymphoma 0.6 0.7 0.4 0.5 0.6 0.4
Non-Hodgkin lymphoma 9.3 10.6 8.0 6.0 7.4 4.8
Multiple myeloma 3.2 3.4 3.0 1.7 2.0 1.5
Leukemia 6.6 7.5 5.7 5.2 6.2 4.3
Other and ill-defined 35.9 36.2 35.6 20.6 23.2 18.5

CNS, central nervous system.

a) Age-adjusted using Segi’s world standard population,

b) Includes the liver and intrahepatic bile duct,

c) Includes the gallbladder and other/unspecified parts of the biliary tract,

d) Includes the lung and bronchus.

Table 3.
The top 10 leading causes of death in Korea, 2017
Rank Cause of death No. of deaths Percentage of all deaths Age-standardized mortality rate per 100,000a)
All causes 285,534 100.0 270.1
1 Cancer 78,863 27.6 76.6
2 Heart disease 30,852 10.8 27.2
3 Cerebrovascular disease 22,745 8.0 19.7
4 Pneumonia 19,378 6.8 15.6
5 Intentional self-harm (suicide) 12,463 4.4 16.7
6 Diabetes mellitus 9,184 3.2 8.0
7 Disease of liver 6,797 2.4 7.5
8 Chronic lower respiratory diseases 6,750 2.4 5.4
9 Hypertensive diseases 5,775 2.0 4.6
10 Transport accidents 5,028 1.8 6.4
Others 87,699 30.7 82.5

Source: Mortality Data, 2017, Statistics Korea [6].

a) Age-adjusted using Segi’s world standard population.

Table 4.
Crude and age-standardized cancer mortality rates by sex in Korea, 2017
Site/Type Crude incidence rate per 100,000
 Age-standardized incidence rate per 100,000a)
Both sexes Men Women Both sexes Men Women
All sites 153.9 191.1 116.9 76.6 111.0 51.2
Lip, oral cavity, and pharynx 2.3 3.6 1.1 1.2 2.1 0.5
Esophagus 2.8 5.0 0.5 1.4 2.9 0.2
Stomach 15.7 20.2 11.2 7.7 11.8 4.6
Colon and rectum 17.0 19.5 14.5 8.1 11.3 5.6
Liverb) 20.9 31.2 10.7 10.9 18.3 4.5
Gallbladderc) 9.2 9.4 9.1 4.3 5.3 3.5
Pancreas 11.3 11.6 10.9 5.6 6.7 4.6
Larynx 0.7 1.4 0.1 0.3 0.8 0.0
Lungd) 35.1 51.9 18.4 16.7 29.4 7.4
Breast 4.9 0.1 9.7 2.9 0.0 5.5
Cervix uteri 1.7 - 3.4 0.9 - 1.7
Corpus uteri 0.6 - 1.2 0.3 - 0.7
Ovary 2.2 - 4.5 1.2 - 2.4
Prostate 3.6 7.1 - 1.5 4.0 -
Testis 0.0 0.1 - 0.0 0.0 -
Kidney 2.0 2.7 1.2 1.0 1.6 0.5
Bladder 2.8 4.3 1.3 1.2 2.5 0.5
Brain and CNS 2.6 2.9 2.3 1.7 2.0 1.4
Thyroid 0.7 0.4 1.0 0.3 0.2 0.4
Hodgkin lymphoma 0.1 0.2 0.0 0.1 0.1 0.0
Non-Hodgkin lymphoma 3.5 3.9 3.1 1.8 2.3 1.4
Multiple myeloma 1.9 2.0 1.8 0.9 1.1 0.8
Leukemia 3.6 4.1 3.1 2.1 2.7 1.7
Other and ill-defined 8.8 9.6 8.0 4.5 5.8 3.5

CNS, central nervous system.

a) Age-adjusted using Segi’s world standard population,

b) Includes the liver and intrahepatic bile duct,

c) Includes the gallbladder and other/unspecified parts of the biliary tract,

d) Includes the lung and bronchus.

Table 5.
Trends in cancer incidence rates from 1999 to 2017 in Korea
Site/Type Both sexes
 Men
 Women
1999 2017 Trend 1
 Trend 2
 1999 2017 Trend 1
 Trend 2
 1999 2017 Trend 1
 Trend 2
Year APC Year APC Year APC Year APC Year APC Year APC
All sites 211.6 264.4 1999-2011 3.5a) 2011-2017 –2.7a) 285.4 291.3 1999-2011 1.6a) 2011-2017 –2.7a) 162.7 251.5 1999-2011 5.6a) 2011-2017 –2.9a)
Lip, oral cavity, and pharynx 3.6 4.3 1999-2017 0.6a) - - 6.1 6.3 1999-2017 –0.1 - - 1.6 2.4 1999-2017 1.5a) - -
Esophagus 4.0 2.6 1999-2017 –2.3a) - - 8.8 5.1 1999-2017 –2.8a) - - 0.6 0.5 1999-2017 –1.3a) - -
Stomach 43.6 32.0 1999-2011 –0.2 2011-2017 –4.7a) 66.1 46.4 1999-2011 –0.4a) 2011-2017 –5.2a) 26.7 19.6 1999-2011 –0.4 2011-2017 –4.2a)
Colon and rectum 20.5 29.7 1999-2010 5.9a) 2010-2017 –4.2a) 26.2 38.8 1999-2010 6.4a) 2010-2017 –4.7a) 16.5 21.8 1999-2010 4.7a) 2010-2017 –3.7a)
Liverb) 27.8 16.5 1999-2010 –1.7a) 2010-2017 –4.5a) 46.6 26.8 1999-2009 –1.8a) 2009-2017 –4.2a) 12.2 7.2 1999-2010 –1.4a) 2010-2017 –4.9a)
Gallbladderc) 6.5 6.6 1999-2004 1.4 2004-2017 –0.3 8.1 8.0 1999-2017 0.0 - - 5.4 5.5 1999-2002 3.3 2002-2017 –0.5a)
Pancreas 5.6 7.1 1999-2017 1.4a) - - 7.8 8.5 1999-2017 0.6a) - - 4.0 5.8 1999-2017 2.3a) - -
Larynx 2.4 1.3 1999-2017 –3.6a) - - 5.0 2.6 1999-2017 –3.8a) - - 0.4 0.1 1999-2007 –9.2a) 2007-2017 –3.5a)
Lungd) 28.4 27.1 1999-2010 0.2 2010-2017 –0.9a) 51.3 42.1 1999-2005 0.0 2005-2017 –1.5a) 12.5 15.5 1999-2011 1.9a) 2011-2017 0.2
Breast 11.0 28.0 1999-2002 10.2a) 2002-2017 4.7a) 0.2 0.2 1999-2017 –0.5 - - 21.4 55.6 1999-2007 6.6a) 2007-2017 4.4a)
Cervix uteri 8.6 4.4 1999-2007 –4.7a) 2007-2017 –3.1a) - - - - - - 16.4 8.7 1999-2007 –4.6a) 2007-2017 –2.8a)
Corpus uteri 1.4 3.7 1999-2017 5.1a) - - - - - - - - 2.8 7.3 1999-2017 5.3a) - -
Ovary 2.7 3.4 1999-2017 1.6a) - - - - - - - - 5.1 6.8 1999-2017 1.9a) - -
Prostate 3.1 12.9 1999-2009 14.6a) 2009-2017 1.5a) 8.4 28.9 1999-2009 13.1a) 2009-2017 0.8 - - - - - -
Testis 0.3 0.5 1999-2015 4.9a) 2015-2017 –2.2 0.5 1.0 1999-2015 4.8a) 2015-2017 –2.4 - - - - - -
Kidney 3.0 6.3 1999-2009 6.5a) 2009-2017 1.9a) 4.6 8.9 1999-2010 5.9a) 2010-2017 1.1a) 1.7 3.8 1999-2008 6.6a) 2008-2017 2.4a)
Bladder 4.6 4.3 1999-2004 2.0a) 2004-2017 –1.2a) 9.0 8.0 1999-2004 1.9a) 2004-2017 –1.5a) 1.6 1.5 1999-2017 –1.0a) - -
Brain and CNS 2.8 2.9 1999-2017 0.2 - - 3.2 3.1 1999-2017 0.2 - - 2.6 2.7 1999-2017 0.2 - -
Thyroid 6.5 36.8 1999-2011 22.2a) 2011-2017 –11.2a) 2.1 17.0 1999-2011 24.8a) 2011-2017 –6.7a) 10.7 57.2 1999-2011 21.9a) 2011-2017 –12.2a)
Hodgkin lymphoma 0.3 0.5 1999-2017 3.9a) - - 0.4 0.6 1999-2017 3.0a) - - 0.1 0.4 1999-2017 5.1a) - -
Non-Hodgkin lymphoma 4.3 6.0 1999-2017 2.3a) - - 5.6 7.4 1999-2017 1.9a) - - 3.3 4.8 1999-2017 2.6a) - -
Multiple myeloma 1.0 1.7 1999-2012 3.7a) 2012-2017 1.0 1.2 2.0 1999-2012 3.5a) 2012-2017 0.4 0.8 1.5 1999-2006 5.9a) 2006-2017 2.3a)
Leukemia 4.7 5.2 1999-2017 0.9a) - - 5.5 6.2 1999-2017 1.0a) - - 3.9 4.3 1999-2017 0.7a) - -
Other and ill-defined 14.9 20.6 1999-2010 2.8a) 2010-2017 1.4a) 18.6 23.2 1999-2017 1.7a) - - 12.3 18.5 1999-2010 3.4a) 2010-2017 1.3a)

APC was calculated using age-standardized incidence data based on Segi’s world standard population. APC, annual percentage change; CNS, central nervous system.

a) Significantly different from zero (p < 0.05),

b) Includes the liver and intrahepatic bile duct,

c) Includes the gallbladder and other/unspecified parts of the biliary tract,

d) Includes the lung and bronchus.

Table 6.
Trends in cancer mortality rates from 1999 to 2017 in Korea
Site/Type Both sexes
 Men
 Women
1999 2017 Trend 1
 Trend 2
 1999 2017 Trend 1
 Trend 2
 1999 2017 Trend 1
 Trend 2
Year APC Year APC Year APC Year APC Year APC Year APC
All sites 114.3 76.6 1999-2002 1.2 2002-2017 –2.8a) 176.6 111.0 1999-2002 1.4 2002-2017 –3.2a) 70.6 51.2 1999-2002 1.1 2002-2017 –2.3a)
Lip, oral cavity, and pharynx 1.1 1.2 1999-2017 –1.7a) - - 2.0 2.1 1999-2017 –2.0a) - - 0.4 0.5 1999-2017 –2.5a) - -
Esophagus 3.1 1.4 1999-2017 –4.4a) - - 6.8 2.9 1999-2017 –4.7a) - - 0.5 0.2 1999-2010 –6.3a) 2010-2017 –1.3
Stomach 23.8 7.7 1999-2003 –3.1a) 2003-2017 –6.8a) 36.9 11.8 1999-2003 –2.4a) 2003-2017 –7.1a) 14.6 4.6 1999-2003 –4.4a) 2003-2017 –6.6a)
Colon and rectum 7.7 8.1 1999-2005 4.6a) 2005-2017 –1.9a) 10.5 11.3 1999-2007 3.3a) 2007-2017 –2.3a) 6.0 5.6 1999-2005 3.9a) 2005-2017 –2.4a)
Liverb) 20.4 10.9 1999-2003 –0.1 2003-2017 –4.0a) 35.3 18.3 1999-2008 –2.6a) 2008-2017 –4.6a) 8.3 4.5 1999-2002 3.4 2002-2017 –4.0a)
Gallbladderc) 5.2 4.3 1999-2001 6.3 2001-2017 –2.4a) 6.8 5.3 1999-2017 –2.2a) - - 4.1 3.5 1999-2001 8.4 2001-2017 –2.4a)
Pancreas 5.4 5.6 1999-2017 0.2a) - - 7.6 6.7 1999-2015 –0.3a) 2015-2017 –3.6 3.9 4.6 1999-2017 0.9a) - -
Larynx 1.6 0.3 1999-2017 –9.3a) - - 3.4 0.8 1999-2017 –8.9a) - - 0.4 0.0 1999-2010 –15.2a) 2010-2017 –8.5a)
Lungd) 22.4 16.7 1999-2001 2.1 2001-2017 –2.2a) 41.5 29.4 1999-2002 2.0 2002-2017 –2.6a) 9.4 7.4 1999-2013 –1.0a) 2013-2017 –4.5a)
Breast 2.2 2.9 1999-2003 3.3a) 2003-2017 1.1a) 0.1 0.0 1999-2017 –4.1a) - - 4.2 5.5 1999-2004 3.1a) 2004-2017 1.3a)
Cervix uteri 1.4 0.9 1999-2003 8.3a) 2003-2017 –5.1a) - - - - - - 2.6 1.7 1999-2003 7.7a) 2003-2017 –4.8a)
Corpus uteri 0.1 0.3 1999-2002 52.8a) 2002-2017 3.1a) - - - - - - 0.1 0.7 1999-2003 35.3a) 2003-2017 3.1a)
Ovary 0.9 1.2 1999-2001 10.3 2001-2017 0.3 - - - - - - 1.7 2.4 1999-2001 9.6 2001-2017 0.7a)
Prostate 0.9 1.5 1999-2004 10.0a) 2004-2017 –0.1 2.6 4.0 1999-2004 10.0a) 2004-2017 –0.7 - - - - - -
Testis 0.0 0.0 1999-2017 –2.6a) - - 0.1 0.0 1999-2017 –3.0a) - - - - - - - -
Kidney 1.1 1.0 1999-2017 –0.2 - - 1.8 1.6 1999-2017 –0.2 - - 0.5 0.5 1999-2017 –0.6 - -
Bladder 1.3 1.2 1999-2001 9.9 2001-2017 –1.7a) 2.6 2.5 1999-2017 –1.6a) - - 0.5 0.5 1999-2001 10.5 2001-2017 –1.8a)
Brain and CNS 1.9 1.7 1999-2002 4.1 2002-2017 –1.9a) 2.2 2.0 1999-2017 –1.5a) - - 1.6 1.4 1999-2017 –1.4a) - -
Thyroid 0.4 0.3 1999-2003 7.5a) 2003-2017 –4.5a) 0.3 0.2 1999-2003 10.2 2003-2017 –4.5a) 0.5 0.4 1999-2004 4.5 2004-2017 –4.9a)
Hodgkin lymphoma 0.0 0.1 1999-2004 22.8a) 2004-2017 –1.6 0.0 0.1 1999-2004 18.8a) 2004-2017 –1.8 0.0 0.0 1999-2014 5.7a) 2014-2017 –32.2
Non-Hodgkin lymphoma 2.1 1.8 1999-2017 –1.0a) - - 3.0 2.3 1999-2017 –1.3a) - - 1.4 1.4 1999-2017 –0.5 - -
Multiple myeloma 0.6 0.9 1999-2003 13.1a) 2003-2017 0.7 0.8 1.1 1999-2003 11.5a) 2003-2017 0.5 0.4 0.8 1999-2005 10.0a) 2005-2017 0.2
Leukemia 2.9 2.1 1999-2017 –1.8a) - - 3.5 2.7 1999-2017 –1.7a) - - 2.4 1.7 1999-2017 –1.9a) - -
Other and ill-defined 7.8 4.5 1999-2017 –2.9a) - - 9.0 5.8 1999-2017 –2.7a) - - 7.0 3.5 1999-2005 –7.1a) 2005-2017 –2.0a)

APC was calculated using age-standardized incidence data based on Segi’s world standard population. APC, annual percentage change; CNS, central nervous system.

a) Significantly different from zero (p < 0.05),

b) Includes the liver and intrahepatic bile duct,

c) Includes the gallbladder and other/unspecified parts of the biliary tract,

d) Includes the lung and bronchus.

Table 7.
Trends in the 5-year relative survival rates (%) by year of diagnosis from 1993 to 2017 in Korea
Site/Type Both sexes
 Men
 Women
1993-1995 1996-2000 2001-2005 2006-2010 2011-2015 2013-2017 Changea) 1993-1995 1996-2000 2001-2005 2006-2010 2011-2015 2013-2017 Changea) 1993-1995 1996-2000 2001-2005 2006-2010 2011-2015 2013-2017 Changea)
All sites 42.9 45.1 54.1 65.5 70.7 70.4 27.5 33.2 36.3 45.6 56.8 63.1 63.5 30.3 55.1 56.4 64.3 74.4 78.4 77.5 22.4
All sites excluding thyroid 41.2 43.3 50.8 59.0 64.2 65.0 23.8 32.7 35.8 44.7 54.6 60.3 61.0 28.3 52.6 53.5 59.1 65.0 69.3 70.1 17.5
Lip, oral cavity, and pharynx 42.1 47.4 54.5 61.0 65.3 66.7 24.6 36.6 41.7 49.6 56.9 61.7 63.7 27.1 59.3 64.5 68.1 72.0 74.4 74.1 14.8
Esophagus 14.0 15.7 21.5 29.9 36.4 38.0 24.0 13.1 14.8 20.7 29.3 36.1 37.5 24.4 25.0 25.9 29.8 37.1 39.7 42.2 17.2
Stomach 43.9 47.3 58.0 68.4 75.9 76.5 32.6 43.9 47.6 58.7 69.1 76.8 77.5 33.6 43.7 46.8 56.6 67.0 74.0 74.6 30.9
Colon and rectum 56.2 58.8 66.9 73.9 76.2 75.0 18.8 56.6 59.8 68.8 75.8 77.9 76.6 20.0 55.7 57.7 64.4 71.1 73.7 72.6 16.9
Liverb) 11.7 14.1 20.5 28.2 34.3 35.6 23.9 10.8 13.8 20.4 28.2 34.8 36.4 25.6 15.0 15.1 20.9 28.3 32.7 33.2 18.2
Gallbladderc) 18.7 20.7 23.1 26.9 28.8 28.9 10.2 18.0 21.1 23.5 27.8 29.5 29.7 11.7 19.3 20.3 22.7 26.0 28.1 28.0 8.7
Pancreas 10.6 8.7 8.4 8.5 10.8 12.2 1.6 10.0 8.3 8.4 8.3 10.2 11.8 1.8 11.5 9.2 8.4 8.8 11.4 12.5 1.0
Larynx 61.6 63.3 66.5 73.2 75.0 77.0 15.4 62.1 63.7 67.1 73.5 75.4 77.4 15.3 56.3 58.9 58.6 68.0 69.2 69.6 13.3
Lungd) 12.5 13.6 16.5 20.2 27.5 30.2 17.7 11.6 12.4 15.3 18.0 23.2 25.2 13.6 15.8 17.5 20.1 26.0 37.2 41.5 25.7
Breast 79.2 83.6 88.6 91.2 92.7 93.2 14.0 77.1 84.3 87.5 89.9 89.4 94.7 17.6 79.2 83.6 88.7 91.2 92.7 93.2 14.0
Cervix uteri 78.3 80.3 81.5 80.7 80.2 80.2 1.9 - - - - - - - 78.3 80.3 81.5 80.7 80.2 80.2 1.9
Corpus uteri 82.9 82.0 84.8 86.5 87.8 88.2 5.3 - - - - - - - 82.9 82.0 84.8 86.5 87.8 88.2 5.3
Ovary 60.1 59.4 61.7 61.2 64.3 64.9 4.8 - - - - - - - 60.1 59.4 61.7 61.2 64.3 64.9 4.8
Prostate 59.1 69.2 81.0 91.9 94.1 94.1 35.0 59.1 69.2 81.0 91.9 94.1 94.1 35.0 - - - - - - -
Testis 87.4 90.4 90.7 93.1 95.1 95.2 7.8 87.4 90.4 90.7 93.1 95.1 95.2 7.8 - - - - - - -
Kidney 64.3 67.0 73.6 78.6 82.4 83.1 18.8 63.5 65.3 73.0 78.4 82.1 83.1 19.6 65.9 70.3 74.9 78.9 83.2 82.9 17.0
Bladder 70.7 73.6 76.0 77.2 76.4 76.8 6.1 71.6 75.1 77.8 79.2 78.3 78.8 7.2 67.1 67.3 69.1 69.1 68.6 68.9 1.8
Brain and CNS 40.4 39.9 41.0 42.9 41.3 40.8 0.4 39.1 38.7 40.3 41.3 39.7 39.2 0.1 42.1 41.4 41.8 44.6 43.0 42.5 0.4
Thyroid 94.5 95.0 98.4 100.0 100.2 100.1 5.6 87.9 89.6 96.0 100.2 100.6 100.4 12.5 95.7 96.0 98.7 99.9 100.1 100.0 4.3
Hodgkin lymphoma 70.1 71.9 76.7 81.0 82.2 83.7 13.6 69.2 69.3 74.7 80.8 81.7 81.3 12.1 71.5 77.3 80.7 81.5 83.1 87.8 16.3
Non-Hodgkin lymphoma 48.3 51.1 56.0 59.4 62.8 63.2 14.9 46.9 49.6 55.0 59.2 62.7 63.9 17.0 50.6 53.3 57.5 59.7 62.9 62.2 11.6
Multiple myeloma 23.5 21.0 29.7 35.0 41.2 43.3 19.8 23.0 19.1 29.8 35.2 40.8 43.6 20.6 24.1 23.3 29.5 34.7 41.7 43.1 19.0
Leukemia 27.5 34.3 42.0 47.7 51.9 53.0 25.5 27.3 33.3 41.8 46.9 52.2 53.6 26.3 27.8 35.5 42.2 48.7 51.5 52.3 24.5
Other and ill-defined 44.5 48.3 57.8 67.6 72.6 74.0 29.5 39.6 44.7 54.0 63.8 69.3 70.9 31.3 50.1 52.6 61.9 71.5 76.0 77.0 26.9

CNS, central nervous system.

a) Absolute percentage change in 5-year relative survival from 1993 to 1995 and 2013 to 2017,

b) Includes the liver and intrahepatic bile duct,

c) Includes the gallbladder and other/unspecified parts of the biliary tract,

d) Includes the lung and bronchus.

Table 8.
Crude and age-standardized rates of cancer prevalence by sex on January 1, 2018 in Korea
Site/Type Crude prevalence rate per 100,000a)
 Age-standardized prevalence rate per 100,000b)
Both sexes Men Women Both sexes Men Women
All sites 3,645.1 3,205.4 4,083.5 2,126.0 1,952.5 2,384.7
Lip, oral cavity, and pharynx 49.7 66.5 32.9 29.5 41.2 19.2
Esophagus 20.3 36.4 4.2 10.7 21.1 2.0
Stomach 564.6 748.3 381.4 301.5 437.6 188.9
Colon and rectum 490.1 583.8 396.6 258.8 343.0 190.6
Liverc) 132.9 199.7 66.3 75.5 120.3 34.8
Gallbladderd) 43.7 44.9 42.5 22.1 25.9 19.1
Pancreas 23.0 24.1 21.8 12.8 14.5 11.4
Larynx 21.5 40.4 2.6 11.2 23.4 1.2
Lunge) 164.4 202.6 126.4 87.0 118.0 63.2
Breast 424.0 3.1 843.5 255.9 1.9 503.7
Cervix uteri 107.2 - 214.1 63.6 - 124.3
Corpus uteri 50.0 - 99.8 30.2 - 59.4
Ovary 41.0 - 81.9 26.9 - 53.5
Prostate 168.7 337.9 - 80.2 189.3 -
Testis 6.7 13.5 - 6.0 11.8 -
Kidney 83.0 111.9 54.2 49.1 69.6 30.7
Bladder 69.5 113.5 25.6 34.8 65.7 11.1
Brain and CNS 22.9 23.5 22.3 19.1 20.1 18.0
Thyroid 790.6 277.7 1,302.0 510.0 183.0 834.8
Hodgkin lymphoma 5.9 7.3 4.4 4.8 5.8 3.8
Non-Hodgkin lymphoma 63.5 72.2 54.7 43.1 51.7 35.0
Multiple myeloma 12.4 13.1 11.8 6.8 7.7 6.0
Leukemia 43.4 48.4 38.4 39.4 44.1 34.6
Other and ill-defined 246.4 236.8 256.0 147.2 156.9 139.4

CNS, central nervous system.

a) Crude prevalence rate: number of prevalent cases divided by the corresponding person-years of observation. Prevalent cases were defined as patients who were diagnosed between January 1, 1999 and December 31, 2017, and who were alive on January 1, 2018. Multiple primary cancer cases were counted multiple times,

b) Age-adjusted using Segi’s world standard population,

c) Includes the liver and intrahepatic bile duct,

d) Includes the gallbladder and other/unspecified parts of the biliary tract,

e) Includes the lung and bronchus.

  • 1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. ArticlePubMed
  • 2. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789–858. PubMedPMC
  • 3. Jung KW, Won YJ, Kong HJ, Lee ES. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2016. Cancer Res Treat. 2019;51:417–30. ArticlePubMedPMCPDF
  • 4. Shin HR, Won YJ, Jung KW, Kong HJ, Yim SH, Lee JK, et al. Nationwide cancer incidence in Korea, 1999~2001: first result using the national cancer incidence database. Cancer Res Treat. 2005;37:325–31. ArticlePubMedPMCPDF
  • 5. Ajiki W, Tsukuma H, Oshima A. Index for evaluating completeness of registration in population-based cancer registries and estimation of registration rate at the Osaka Cancer Registry between 1966 and 1992 using this index. Nihon Koshu Eisei Zasshi. 1998;45:1011–7. PubMed
  • 6. Statistics Korea [Internet]. Daejeon: Statistics Korea; 2018. [cited 2020 Feb 28]. Available from: http://kosis.kr
  • 7. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. International classification of diseases for oncology. 3rd ed. 1st rev. Geneva: World Health Organization; 2013.
  • 8. World Health Organization. International statistical classification of diseases and related health problems, 10th rev. Geneva: World Health Organization; 1994.
  • 9. Cancer incidence in five continents. Vol. XI. Chapter 3. Classification and coding [Internet]. Lyon: International Agency for Research on Cancer; 2020. [cited 2020 Feb 28]. Available from: http://ci5.iarc.fr/CI5-XI/Pages/Chapter3.aspx
  • 10. Young JL Jr, Roffers SD, Ries LA, Fritz AG, Hurlbut AA. SEER summary staging manual 2000: codes and coding instructions, National Cancer Institute, NIH Pub. No. 01-4969. Bethesda, MD: National Cancer Institute; 2001.
  • 11. Cancer incidence in five continents. Vol. XI. Chapter 7. Age standardization [Internet]. Lyon: International Agency for Research on Cancer; 2020. [cited 2020 Feb 28]. Available from: http://ci5.iarc.fr/CI5-XI/Pages/Chapter7.aspx
  • 12. Segi M. Cancer mortality for selected sites in 24 countries (1950-1957). Sendai: Tohoku University School of Medicine; 1960.
  • 13. Surveillance Research Program. Joinpoint Regression Program, version 4.7.0.0 [Internet]. Bethesda, MD: National Cancer Institute; 2019. [cited 2019 Dec 1]. Available from: https://surveillance.cancer.gov/joinpoint/
  • 14. Ederer F, Heise H. Instructions to IBM 650 programmers in processing survival computations. Methodological note, No. 10. Bethesda, MD: National Cancer Institute; 1959.
  • 15. Paul Dickman [Internet]. Stockholm: PaulDickman.com; 2016. [cited 2020 Feb 28]. Available from: http://www.pauldickman.com

Figure & Data

REFERENCES

    Citations

    Citations to this article as recorded by  
    • Health-related quality of life in long-term early-stage breast cancer survivors compared to general population in Korea
      Thi Xuan Mai Tran, So-Youn Jung, Eun-Gyeong Lee, Heeyoun Cho, Na Yeon Kim, Sungkeun Shim, Ho Young Kim, Danbee Kang, Juhee Cho, Eunsook Lee, Yoonjung Chang, Hyunsoon Cho
      Journal of Cancer Survivorship.2025; 19(2): 487.     CrossRef
    • An anonymized, de-identified registry study protocol to determine the effectiveness and safety of weight loss with enavogliflozin in patients with type 2 diabetes mellitus
      Hyunji Sang, Sunyoung Kim, Jiyoung Hwang, Selin Woo, Jaewon Kim, Dong Keon Yon, Sang Youl Rhee, Aleksandra Klisic
      PLOS ONE.2025; 20(1): e0315603.     CrossRef
    • Antitumor effects of immunotherapy combined with BRAF and MEK inhibitors in BRAF V600E metastatic colorectal cancer
      Eunyoung Tak, Hye-In An, Amy Sinyoung Lee, Kyuyoung Han, Jiwan Choi, Hyung-don Kim, Yong Sang Hong, Sun Young Kim, Eun Kyung Choi, Jeong Eun Kim, Tae Won Kim
      Cancer Immunology, Immunotherapy.2025;[Epub]     CrossRef
    • Gastric Cancer Screening in the United States: A Review of Current Evidence, Challenges, and Future Perspectives
      Dan Li, Douglas R. Morgan, Juan E. Corral, Elizabeth A. Montgomery, Arnoldo Riquelme, Shailja C. Shah
      American Journal of Gastroenterology.2025;[Epub]     CrossRef
    • USP18 Confers Paclitaxel Resistance in Non‐Small Cell Lung Cancer by Stabilizing SHANK1 Expression Via Deubiquitination
      Lixun Chai, Yanlong Sun, Yunfei Wang, Chenhui Zhao
      Journal of Biochemical and Molecular Toxicology.2025;[Epub]     CrossRef
    • Development of a home health care service platform for ostomy patient management
      Seongwoo Yang, Ji Won Park, Hyuk Hur, Min Jung Kim, Seung-Yong Jeong, Kyounghoon Park, Ik Yong Kim
      Annals of Coloproctology.2024; 40(1): 36.     CrossRef
    • Sex Difference of Colon Adenoma Pathway and Colorectal Carcinogenesis
      Yonghoon Choi, Nayoung Kim
      The World Journal of Men's Health.2024; 42(2): 256.     CrossRef
    • Second-line chemoimmunotherapy with nivolumab and paclitaxel in immune-related biomarker-enriched advanced gastric cancer: a multicenter phase Ib/II study
      Choong-kun Lee, Jii Bum Lee, Se Jung Park, Jingmin Che, Woo Sun Kwon, Hyo Song Kim, Minkyu Jung, Seulkee Lee, Sook Ryun Park, Dong-Hoe Koo, Hyun Woo Lee, Woo Kyun Bae, Hei-Cheul Jeung, In Gyu Hwang, Hyunki Kim, Chung Mo Nam, Hyun Cheol Chung, Sun Young Rh
      Gastric Cancer.2024; 27(1): 118.     CrossRef
    • Is There a Difference in the Incidence of Depression between Radiation and Surgical Treatments in Patients with Prostate Cancer?
      Bum Sik Tae, Sun Tae Ahn, Jung Wan Yoo, Min Sung Song, Hoon Choi, Jae Hyun Bae, Jae Young Park
      The World Journal of Men's Health.2024; 42(1): 237.     CrossRef
    • Association between Sarcopenia and Survival in Patients Undergoing Gamma Knife Surgery for Brain Metastasis from Breast Cancer: A Retrospective Single-centre Cohort Study
      J.-H. Sim, Y.-H. Kim, S. Lee, H.-S. Park, W.U. Koh, D.-M. Jang, W.-J. Choi
      Clinical Oncology.2024; 36(2): e87.     CrossRef
    • Risk of Pancreatic Cancer After Acute Pancreatitis: A Retrospective Analysis of the Korean National Sample Cohort
      Sung Hoon Jeong, Kyungduk Hurh, Eun-Cheol Park, Ja-ho Leigh, Seung Hoon Kim, Sung-In Jang
      Journal of Korean Medical Science.2024;[Epub]     CrossRef
    • Trends in the incidence and survival outcomes of endometrial cancer in Korea: a nationwide population-based cohort study
      Seung-Hyuk Shim, Jiwon Lim, Ji Hyun Kim, Yeon Jee Lee, Hyeong In Ha, Myong Cheol Lim, Young-Joo Won
      Journal of Gynecologic Oncology.2024;[Epub]     CrossRef
    • Trends in colorectal cancer incidence according to an increase in the number of colonoscopy cases in Korea
      Ga Hee Kim, Yeong Chan Lee, Tae Jun Kim, Sung Noh Hong, Dong Kyung Chang, Young-Ho Kim, Dong-Hoon Yang, Chang Mo Moon, Kyunga Kim, Hyun Gun Kim, Eun-Ran Kim
      World Journal of Gastrointestinal Oncology.2024; 16(1): 51.     CrossRef
    • Comparative Sensing and Judgment Control System for Temperature Maintenance for Optimal Treatment in Hyperthermic Intraperitoneal Chemotherapy Surgery
      Tae-Hyeon Lee, Kicheol Yoon, Sangyun Lee, Woong Rak Choi, Kwang Gi Kim
      Sensors.2024; 24(2): 596.     CrossRef
    • Burden of Stomach Cancer Incidence, Mortality, Disability-Adjusted Life Years, and Risk Factors in 204 Countries, 1990–2019: An Examination of Global Burden of Disease 2019
      Rajesh Sharma
      Journal of Gastrointestinal Cancer.2024; 55(2): 787.     CrossRef
    • Surgical treatment of esophageal cancer
      Seong Yong Park
      Journal of the Korean Medical Association.2024; 67(2): 124.     CrossRef
    • RE.GA.IN.: the Real-world Gastritis Initiative–updating the updates
      Massimo Rugge, Robert M Genta, Peter Malfertheiner, Mario Dinis-Ribeiro, Hashem El-Serag, David Y Graham, Ernst J Kuipers, Wai Keung Leung, Jin Young Park, Theodore Rokkas, Christian Schulz, Emad M El-Omar
      Gut.2024; : gutjnl-2023-331164.     CrossRef
    • Temporal Trend in Uptake of the National General Health Checkups and Cancer Screening Program among Korean Women with Breast Cancer
      Thi Xuan Mai Tran, Soyeoun Kim, Chihwan Cha, Boyoung Park
      Cancer Research and Treatment.2024; 56(2): 522.     CrossRef
    • Monte Carlo Simulation-Based Mammographic Anti-Scatter Grids to Evaluate Performance of Digital Mammography Detector
      Yeji Kim, Hyejin Jo, Yongsu Yoon
      Journal of Radiological Science and Technology.2024; 47(1): 1.     CrossRef
    • Sex differences in prognosis factors in patients with lung cancer: A nationwide retrospective cohort study in Korea
      Youn Huh, Yeo Ju Sohn, Hae-Rim Kim, Hyejin Chun, Hwa Jung Kim, Ki Young Son, Dong Keon Yon
      PLOS ONE.2024; 19(5): e0300389.     CrossRef
    • Epidemiology of Non-Emergent Cancer-Related Emergency Department Visits in Korea between 2016 and 2020
      Sun Young Lee, Young Sun Ro, Sang Do Shin, Seong Jung Kim, Eujene Jung
      Yonsei Medical Journal.2024; 65(7): 418.     CrossRef
    • Different trends of gastric cancer in China, Japan, Republic of Korea and United States of America
      Fangrui Zhao, Dashuai Yang, Yanfang Lan, Xiangpan Li
      iScience.2024; 27(6): 110074.     CrossRef
    • Gastric Metastasis Mimicking Early Gastric Cancer from Invasive Ductal Carcinoma of the Breast: Case Report and Literature Review
      Kwon Cheol Yoo, Dae Hoon Kim, Sungmin Park, HyoYung Yun, Dong Hee Ryu, Jisun Lee, Seung-Myoung Son
      Medicina.2024; 60(6): 980.     CrossRef
    • Cancer survival statistics in China 2019–2021: a multicenter, population-based study
      Hongmei Zeng, Rongshou Zheng, Kexin Sun, Maigeng Zhou, Shaoming Wang, Li Li, Ru Chen, Bingfeng Han, Meicen Liu, Jinhui Zhou, Mengyuan Xu, Lijun Wang, Peng Yin, Baohua Wang, Jinling You, Jing Wu, Wenqiang Wei, Jie He
      Journal of the National Cancer Center.2024; 4(3): 203.     CrossRef
    • Trends in breast density and other risk factors for breast cancer and associations with trends in the incidence of breast cancer in Korean women
      Soyeoun Kim, Thi Xuan Mai Tran, Boyoung Park
      Maturitas.2024; 189: 108070.     CrossRef
    • Korean National Burden of Disease: The Importance of Diabetes Management
      Chung-Nyun Kim, Yoon-Sun Jung, Young-Eun Kim, Minsu Ock, Seok-Jun Yoon
      Diabetes & Metabolism Journal.2024; 48(4): 518.     CrossRef
    • Survival analysis of gynecological cancers in Southeast China, 2011–2020: A population-based study
      Sufang Deng, Yan Zhou, Jie Lin, Zhisheng Xiang, Linying Liu, Ning Xie, Haijuan Yu, Yang Sun
      Cancer Epidemiology.2024; 92: 102641.     CrossRef
    • Medical Maximizing Orientation and the Desire for Low-Value Screening: An Examination of Mediating Mechanisms
      Soela Kim
      Medical Decision Making.2024; 44(8): 927.     CrossRef
    • Experiences of Cancer Survivors Returning to Work in Korean Society: A Qualitative Study
      Kisook Kim, Hyohyoen Yoon, Booyoung Oh
      Asian Oncology Nursing.2024; 24(3): 114.     CrossRef
    • A 10-Gene Signature to Predict the Prognosis of Early-Stage Triple-Negative Breast Cancer
      Chang Min Kim, Kyong Hwa Park, Yun Suk Yu, Ju Won Kim, Jin Young Park, Kyunghee Park, Jong-Han Yu, Jeong Eon Lee, Sung Hoon Sim, Bo Kyoung Seo, Jin Kyeoung Kim, Eun Sook Lee, Yeon Hee Park, Sun-Young Kong
      Cancer Research and Treatment.2024; 56(4): 1113.     CrossRef
    • Advancement in schiff base complexes for treatment of colon cancer
      Afaf Murtadha Kadhum, Shaimaa Hassan Mallah, Azal Shakir Waheeb, Abbas Washeel Salman, Ayesha Zafar, Nafeesa Sajjad Ahmad, Saira Siraj, Muhammad Adnan Iqbal
      Reviews in Inorganic Chemistry.2024;[Epub]     CrossRef
    • The diagnosis and management of small and indeterminate lymph nodes in papillary thyroid cancer: preoperatively and intraoperatively
      Ang Hu, Jiahe Tian, Xinpei Deng, Zhongyu Wang, Yin Li, Jianwei Wang, Longzhong Liu, Qiuli Li
      Frontiers in Endocrinology.2024;[Epub]     CrossRef
    • Proteogenomic analysis dissects early-onset breast cancer patients with prognostic relevance
      Kyong-Ah Yoon, Youngwook Kim, So-Youn Jung, Jin-Sun Ryu, Kyung-Hee Kim, Eun-Gyeong Lee, Heejung Chae, Youngmee Kwon, Jaegil Kim, Jong Bae Park, Sun-Young Kong
      Experimental & Molecular Medicine.2024; 56(11): 2382.     CrossRef
    • Adherence to the American Cancer Society guidelines on nutrition and physical activity for cancer survivors and biomarkers of inflammation among breast cancer survivors
      Minji Kang, Sihan Song, Hyun Jeong Cho, Zisun Kim, Hyun Jo Youn, Jihyoung Cho, Jun Won Min, Yoo Seok Kim, Sang-Woon Choi, Jung Eun Lee
      Epidemiology and Health.2024; 46: e2024026.     CrossRef
    • Safety and effectiveness of aflibercept in combination with FOLFIRI in Korean patients with metastatic colorectal cancer who received oxaliplatin-containing regimen
      Seung-Hoon Beom, Jong Gwang Kim, Seung Hyuk Baik, Seong Hoon Shin, Inkeun Park, Young Suk Park, Myung-Ah Lee, Soohyeon Lee, So-Yeon Jeon, Sae-Won Han, Myoung Hee Kang, Jisu Oh, Jin Soo Kim, Jin Young Kim, Mi Sun Ahn, Dae Young Zang, Byung-Noe Bae, Hong Ja
      Journal of Cancer Research and Clinical Oncology.2023; 149(3): 1131.     CrossRef
    • The impact of the incidence of diabetic complications on mortality in colorectal cancer patients with diabetes: A nationwide study
      Woo-Ri Lee, Kyu-Tae Han, Yoon Jung Chang, Seojin Park, Woorim Kim
      International Journal of Colorectal Disease.2023;[Epub]     CrossRef
    • Associations Between Chronic Rhinosinusitis and Cancers: A Nationwide Population‐Based Cohort Study
      Yung Jin Jeon, Yeon‐Hee Joo, Hyun‐Jin Cho, Sang‐Wook Kim, Bumjung Park, Hyo Geun Choi
      The Laryngoscope.2023; 133(5): 1044.     CrossRef
    • Associations of body mass index and weight change with circulating levels of high‐sensitivity C‐reactive protein, proinflammatory cytokines, and adiponectin among breast cancer survivors
      Hyun Jeong Cho, Sihan Song, Zisun Kim, Hyun Jo Youn, Jihyoung Cho, Jun Won Min, Yoo Seok Kim, Sang‐Woon Choi, Jung Eun Lee
      Asia-Pacific Journal of Clinical Oncology.2023; 19(1): 113.     CrossRef
    • Cancer-associated vasculitides: a single-centre case series
      Hyunsue Do, Jung Yoon Pyo, Sung Soo Ahn, Jason Jungsik Song, Yong-Beom Park, Sang-Won Lee
      Clinical Rheumatology.2023; 42(1): 151.     CrossRef
    • Self-Management Strategy Clustering, Quality of Life, and Health Status in Cancer Patients Considering Cancer Stages
      Ju Youn Jung, Young Ho Yun
      International Journal of Behavioral Medicine.2023; 30(5): 769.     CrossRef
    • Estimating Age-Specific Mean Sojourn Time of Breast Cancer and Sensitivity of Mammographic Screening by Breast Density among Korean Women
      Eunji Choi, Mina Suh, So-Youn Jung, Kyu-Won Jung, Sohee Park, Jae Kwan Jun, Kui Son Choi
      Cancer Research and Treatment.2023; 55(1): 136.     CrossRef
    • Frequent Intraluminal Growth of Large Muscular Veins in Surgically Resected Colorectal Cancer Tissues: A 3-Dimensional Pathologic Reconstruction Study
      Dongjun Jung, Junyoung Shin, Jihyun Park, Jaehoon Shin, You-Na Sung, Yeseul Kim, Seungyeon Yoo, Byong-Wook Lee, Sung-Wuk Jang, In Ja Park, Laura D. Wood, Chan-Gi Pack, Ralph H. Hruban, Seung-Mo Hong
      Modern Pathology.2023; 36(3): 100082.     CrossRef
    • Increasing disparities in the proportions of active treatment and 5-year overall survival over time by age groups among older patients with gastric cancer in Korea
      Hyun-Soo Zhang, Dong-Woo Choi, Han Sang Kim, Hye Jung Kang, Hoyol Jhang, Wonjeong Jeong, Chung Mo Nam, Sohee Park
      Frontiers in Public Health.2023;[Epub]     CrossRef
    • Comparison of Treatment Patterns and Clinical Outcomes by Gender in Locally Advanced Head and Neck Squamous Cell Carcinoma (KCSG HN13-01)
      Yun-Gyoo Lee, Eun Joo Kang, Bhumsuk Keam, Jin-Hyuk Choi, Jin-Soo Kim, Keon Uk Park, Kyoung Eun Lee, Keun-Wook Lee, Min Kyoung Kim, Hee Kyung Ahn, Seong Hoon Shin, Hye Ryun Kim, Sung-Bae Kim, Hyo Jung Kim, Hwan Jung Yun
      Cancers.2023; 15(2): 471.     CrossRef
    • Long-term Surgical Outcomes in Oligometastatic Non-small Cell Lung Cancer: A Single-Center Study
      Seungmo Yoo, Won Chul Cho, Geun Dong Lee, Sehoon Choi, Hyeong Ryul Kim, Yong-Hee Kim, Dong Kwan Kim, Seung-Il Park, Jae Kwang Yun
      Journal of Chest Surgery.2023; 56(1): 25.     CrossRef
    • Trends in Survival and Surgical Methods in Patients Surgically Treated for Metastatic Spinal Tumors: 25-Year Experience in a Single Institution
      Se-Jun Park, Jin-Sung Park, Chong-Suh Lee, Byeong-Jik Kang, Choong-Won Jung
      Clinics in Orthopedic Surgery.2023; 15(1): 109.     CrossRef
    • The impact of the 30-day postoperative complications on the quality of life following gastrectomy for gastric carcinoma: A prospective study
      Aelee Jang, Oh Jeong
      European Journal of Surgical Oncology.2023; 49(5): 983.     CrossRef
    • Metachronous gastric neoplasm beyond 5 years after endoscopic resection for early gastric cancer
      Eunwoo Lee, Sang Gyun Kim, Bokyung Kim, Jue Lie Kim, Jung Kim, Hyunsoo Chung, Soo-Jeong Cho
      Surgical Endoscopy.2023; 37(5): 3901.     CrossRef
    • Transcatheter Arterial Embolization for Palliation of Uterine Body Cancer Bleeding
      Jaeyeon Choi, Ji Hoon Shin, Hee Ho Chu
      Journal of the Korean Society of Radiology.2023; 84(3): 606.     CrossRef
    • Equating Two Health-related Quality of Life Instruments Applied to Cancer Survivors Who Underwent Palliative Care
      Bongsam Choi, Heesu Kim, Sunhwi Bang, Byunggwan Kim, Jaekwang Shim
      Physical Therapy Korea.2023; 30(1): 32.     CrossRef
    • Soybean product consumption decreases risk of gastric cancer: results from the Health Examinees Study
      Woo-Kyoung Shin, Hwi-Won Lee, Dan Huang, Katherine De la Torre, Sukhong Min, Aesun Shin, Jong-koo Lee, Jung Eun Lee, Daehee Kang
      European Journal of Nutrition.2023; 62(4): 1743.     CrossRef
    • The global, regional, and national burden of stomach cancer among adolescents and young adults in 204 countries and territories, 1990–2019: A population-based study
      Ziqiang Zhang, Jun Wang, Ning Song, Liubin Shi, Jianjun Du
      Frontiers in Public Health.2023;[Epub]     CrossRef
    • The association between weight change after gastric cancer surgery and type 2 diabetes risk: A nationwide cohort study
      Yeongkeun Kwon, Jane Ha, Dohyang Kim, Jinseub Hwang, Shin‐Hoo Park, Jin‐Won Kwon, Sungsoo Park
      Journal of Cachexia, Sarcopenia and Muscle.2023; 14(2): 826.     CrossRef
    • Safety and Efficacy of Bojungikki-Tang in Advanced NSCLC Patients Receiving Treatment with Immune Checkpoint Inhibitors: Protocol for a Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Trial
      Mi Mi Ko, Mi-Kyung Jeong, Chang Min Choi, Seung Hyeun Lee, Jaemoo Chun, Jin-Mu Yi, Ho Jang, Sung Yong Lee
      International Journal of Environmental Research and Public Health.2023; 20(5): 4507.     CrossRef
    • Association of Fermented Products with Risk of Cancer Recurrence and Mortality among Breast Cancer Survivors: A Prospective Cohort Study
      Jubin Yang, Minsung Chung, Yongsoon Park
      Nutrition and Cancer.2023; 75(4): 1189.     CrossRef
    • Neutrophil to lymphocyte ratio can predict overall survival in patients with stage II to III colorectal cancer
      Yerim Cho, Su Bee Park, Jin Young Yoon, Min Seob Kwak, Jae Myung Cha
      Medicine.2023; 102(11): e33279.     CrossRef
    • Communication-based strategies to curb the overuse of low-value cancer screening
      Soela Kim, Jennifer L Monahan, Young Kyung Do
      Journal of Communication.2023; 73(5): 399.     CrossRef
    • Integration of Handheld Ultrasound or Automated Breast Ultrasound among Women with Negative Mammographic Screening Findings: A Multi-center Population-based Study in China
      Wenhui Ren, Huijiao Yan, Xuelian Zhao, Mengmeng Jia, Shaokai Zhang, Junpeng Zhang, Zhifang Li, Lingling Ming, Yongdong Zhang, Huibing Li, Lichun He, Xiaofeng Li, Xia Cheng, Lu yue, Wenjing Zhou, Youlin Qiao, Fanghui Zhao
      Academic Radiology.2023; 30: S114.     CrossRef
    • Epidemiology of Second Non-breast Primary Cancers among Survivors of Breast Cancer: A Korean Population–Based Study by the SMARTSHIP Group
      Haeyoung Kim, Su SSan Kim, Ji Sung Lee, Jae Sun Yoon, Hyun Jo Youn, Hyukjai Shin, Jeong Eon Lee, Se Kyung Lee, Il Yong Chung, So-Youn Jung, Young Jin Choi, Jihyoung Cho, Sang Uk Woo
      Cancer Research and Treatment.2023; 55(2): 580.     CrossRef
    • A Nationwide Study of Differences in Surgical Treatment Rates and Oncological Outcomes for Prostate Cancer according to Economic Status and Region
      Sangjun Yoo, Sohee Oh, Min Chul Cho, Hwancheol Son, Hyeon Jeong
      Cancer Research and Treatment.2023; 55(2): 652.     CrossRef
    • Incidence of dysphagia requiring medical attention in various types of cancers: A nationwide population-based cohort study
      SuYeon Kwon, Gowun Kim, Seungwoo Cha, Kyungdo Han, Nam-Jong Paik, Won-Seok Kim
      Supportive Care in Cancer.2023;[Epub]     CrossRef
    • Risk of Metabolic Syndrome and Fatty Liver Diseases in Gastric Cancer Survivors: A Propensity Score-Matched Analysis
      Sang Jo Han, Su Jung Baik, Young Hoon Yoon, Jie Hyun Kim, Hye Sun Lee, Soyoung Jeon, Hyojin Park
      The Korean Journal of Gastroenterology.2023; 81(4): 154.     CrossRef
    • Efficacy and Safety of Chemotherapy in Elderly Patients with Unresectable Pancreatic Cancer
      Byung Soo Kwan, Ok Jae Lee, Hyun Jin Kim, Kwang Min Kim, Sang Goon Shim, Dae Hyeon Cho, Sung Min Kong, Jun Young Kim, Jun Ho Ji
      Journal of Clinical Medicine.2023; 12(9): 3334.     CrossRef
    • Changes in the treatment rate of patients newly diagnosed with stage IV cancer near the end of life from 2012 to 2017 in Korea
      Kyuwoong Kim, Hyun Jung Jho, So Jung Park, Bohyun Park, Jin Young Choi
      Epidemiology and Health.2023; 45: e2023021.     CrossRef
    • Exploring the Latent Trait and the Measurement Properties of Korean World Health Organization Quality of Life-BREF Measure Applied to Cancer Survivors
      Bongsam Choi
      Physical Therapy Korea.2023; 30(2): 120.     CrossRef
    • Survival rate of thyroid cancer in the Asian countries: a systematic review and meta-analysis study
      Soheil Hassanipour, Reza Zare, Alireza Shahedi, Hamed Delam
      Endocrine.2023; 82(2): 237.     CrossRef
    • Nuclear complement C3b promotes paclitaxel resistance by assembling the SIN3A/HDAC1/2 complex in non-small cell lung cancer
      Xiaochao Wang, Yan Hao, Jianfeng Chen, Peipei Ding, Xinyue Lv, Danlei Zhou, Ling Li, Luying Li, Yanqing Xu, Yumeng Zhu, Wei Zhang, Lu Chen, Tian Liao, Xianghuo He, Qing-Hai Ji, Weiguo Hu
      Cell Death & Disease.2023;[Epub]     CrossRef
    • Comparison of cardiovascular disease risk in women with and without breast cancer: secondary data analysis with the 2014–2018 korean national health and nutrition examination survey
      Seongmi Choi, Na-Jin Park, Mihui Kim, Kijun Song, JiYeon Choi
      BMC Public Health.2023;[Epub]     CrossRef
    • Impact of pre‐ and post‐diagnosis physical activity on the mortality of patients with cancer: Results from the Health Examinees‐G study in Korea
      Jaesung Choi, Joo‐Yong Park, Ji‐Eun Kim, Miyoung Lee, Kyuwan Lee, Jong‐Koo Lee, Daehee Kang, Aesun Shin, Ji‐Yeob Choi
      Cancer Medicine.2023; 12(15): 16591.     CrossRef
    • Differential risk of 23 site‐specific incident cancers and cancer‐related mortality among patients with metabolic dysfunction‐associated fatty liver disease: a population‐based cohort study with 9.7 million Korean subjects
      Goh Eun Chung, Su Jong Yu, Jeong‐Ju Yoo, Yuri Cho, Kyu‐na Lee, Dong Wook Shin, Yoon Jun Kim, Jung‐Hwan Yoon, Kyungdo Han, Eun Ju Cho
      Cancer Communications.2023; 43(8): 863.     CrossRef
    • Analysis of Interaction between Twenty-Seven Pyrimidinone Derivatives with XIAP Using a Theoretical Model
      Lauro Figueroa-Valverde, Francisco Diaz-Cedillo, Marcela Rosas-Nexticapa, Catalina Cervantes-Ortega, Magdalena Alvarez-Ramirez, Virginia Mateu-Armand, Maria Lopez-Ramos
      Clinical Cancer Investigation Journal.2023; 12(3): 13.     CrossRef
    • Associations between Physical Activity and Incidence of Cancer among Overweight Adults in Korea: Results from the Health Examinees-G Study
      Jaesung Choi, JooYong Park, Ji-Eun Kim, Miyoung Lee, Daehee Kang, Aesun Shin, Ji-Yeob Choi
      Cancer Prevention Research.2023; 16(7): 405.     CrossRef
    • The Design of an Automatic Temperature Compensation System through Smart Heat Comparison/Judgment and Control for Stable Thermal Treatment in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Surgery
      Kicheol Yoon, Sangyun Lee, Tae-Hyeon Lee, Kwang Gi Kim
      Sensors.2023; 23(15): 6722.     CrossRef
    • Cost-Effectiveness of Active Surveillance Compared to Early Surgery of Small Papillary Thyroid Cancer: A Retrospective Study on a Korean Population
      Han-Sang Baek, Jeonghoon Ha, Kwangsoon Kim, Jaseong Bae, Jeong Soo Kim, Sungju Kim, Dong-Jun Lim, Chulmin Kim
      Journal of Korean Medical Science.2023;[Epub]     CrossRef
    • Supramaximal Resection for Glioblastoma: Redefining the Extent of Resection Criteria and Its Impact on Survival
      Tae Hoon Roh, Se-Hyuk Kim
      Brain Tumor Research and Treatment.2023; 11(3): 166.     CrossRef
    • The effects of hospice care on healthcare expenditure among cancer patients
      Hoyol Jhang, Wonjeong Jeong, Hyun-Soo Zhang, Dong-Woo Choi, Hyejung Kang, Sohee Park
      BMC Health Services Research.2023;[Epub]     CrossRef
    • Association Between Distress at Diagnosis and Disease-free Survival Among Patients With Resectable Colon Cancer: A Large Cohort Study
      Jung Kyong Shin, Danbee Kang, Soohyun Kim, Youngeun Choi, Woo Yong Lee, Seong Hyeon Yun, Yong Beom Cho, Jung Wook Huh, Yoon Ah Park, Juhee Cho, Hee Cheol Kim
      Annals of Surgery.2023; 278(3): e534.     CrossRef
    • Impact of health disparities on national breast cancer screening participation rates in South Korea
      Fatima Nari, Juwon Park, Nayeon Kim, Dong Jin Kim, Jae Kwan Jun, Kui Son Choi, Mina Suh
      Scientific Reports.2023;[Epub]     CrossRef
    • Combinations of lifestyle behaviors and cancer risk among Korean adults
      Ngoc Minh Luu, Thi Tra Bui, Thi Phuong Thao Tran, Thi Huyen Trang Nguyen, Jin-Kyoung Oh
      Scientific Reports.2023;[Epub]     CrossRef
    • Comparison of health literacy and health behaviors between Korean women with and without breast cancer
      Goeun Chung, Hye-Jin Kim
      Journal of Korean Biological Nursing Science.2023; 25(3): 205.     CrossRef
    • Development of a Breast Cancer Risk Prediction Model Incorporating Polygenic Risk Scores and Nongenetic Risk Factors for Korean Women
      Jihye Choi, Tae-Woong Ha, Hye-Mi Choi, Han-Byoel Lee, Hee-Chul Shin, Woosung Chung, Wonshik Han
      Cancer Epidemiology, Biomarkers & Prevention.2023; 32(9): 1182.     CrossRef
    • Expert Opinion Survey on Proposals for Safety Management of Prescription Opioids
      Seunghyun Cheon, Seo-Yong Choi, Sang-Hyeon Oh, Myoungon Eun, Jungbo Kim, Songhee Park, Soyoung Park, Ryang Soon Im, Su Bin Lee, Hye Won Han, Jungwha Lee, Hyun-A Sohn, Younghee Lee, Sook Hee An, Jee-Eun Chung
      Journal of Korean Society of Health-System Pharmacists.2023; 40(3): 326.     CrossRef
    • Gastric cancer: A unique opportunity to shift the paradigm of cancer disparities in the United States
      Alexandra Adams, Atish Gandhi, Haejin In
      Current Problems in Surgery.2023; 60(10): 101382.     CrossRef
    • The increased risk of colorectal cancer in the women who underwent hysterectomy from the South Korean National Health Insurance Database
      Jin -Sung Yuk, Seung-Woo Yang, Sang-Hee Yoon, Myoung Hwan Kim, Yong-Soo Seo, Yujin Lee, Jungbin Kim, Keunho Yang, Geumhee Gwak, Hyunjin Cho
      BMC Women's Health.2023;[Epub]     CrossRef
    • Anticancer Properties of Some Selected Plant Phenolic Compounds: Future Leads for Therapeutic Development
      N. Maheshwari, M.C. Sharma
      Journal of Herbal Medicine.2023; 42: 100801.     CrossRef
    • High Expression of NRF2 and Low Expression of KEAP1 Predict Worse Survival in Patients With Operable Triple-Negative Breast Cancer
      Young Sub Lee, Jun Kang, Eun Sun Jung, Ahwon Lee
      Journal of Breast Cancer.2023; 26(5): 461.     CrossRef
    • Comparison of Clinicopathological Features and Prognosis of Mucinous Gastric Carcinoma and other Gastric Cancers: A Retrospective Study of 4,417 Patients
      Yubo Ma, Shengjie Zhang, Yi Wang, Can Hu, Jinxia Chen, Chuhong Pang, Chen Liang, Li Yuan, Yian Du
      Journal of Gastrointestinal Surgery.2023; 27(11): 2352.     CrossRef
    • The effect of the introduction of the national lung cancer screening program on short-term mortality in Korea
      Woorim Kim, Sang Chul Lee, Woo-Ri Lee, Sungyoun Chun
      Lung Cancer.2023; 186: 107412.     CrossRef
    • Subjective perceptions of 8, 11 and 14°C chemotherapy liquid cooled gloves and socks
      Sang-Hyun Roh, Yoon Jeong Baek, Hye-Lin Lee, Do-Shin Lee, Chan Hyeok Kang, Joo-Young Lee
      Fashion and Textiles.2023;[Epub]     CrossRef
    • Limb Amputations in Cancer: Modern Perspectives, Outcomes, and Alternatives
      Thien Huong N. Huynh, Davis R. Kuruvilla, Matthew D. Nester, Guston Zervoudakis, G. Douglas Letson, David M. Joyce, Odion T. Binitie, Alexander L. Lazarides
      Current Oncology Reports.2023; 25(12): 1457.     CrossRef
    • Risk Predictors of Post-Embolization Syndrome after Transarterial Chemoembolization by Sex: A Retrospective Study
      Han Byeol Lim, Myoung Soo Kim
      Korean Journal of Adult Nursing.2023; 35(4): 418.     CrossRef
    • Characteristics of Defecation Function Related Quality of Life According to Cancer Location in Colorectal Cancer Survivors
      Okimitsu Oyama, Dong-Hyuk Park, Mi-Kyung Lee, Ji-yong Byeon, Eun Byeol Lee, Jae-Youn Chung, Hye Jeong Jung, Jisu Park, Taeil Kim, Sun Ha Jee, Nam Kyu Kim, Justin Y Jeon
      Asian Oncology Nursing.2022; 22(4): 225.     CrossRef
    • Socioeconomic Disparities in Gastric Cancer and Identification of a Single SES Variable for Predicting Risk
      Srawani Sarkar, Marc J. Dauer, Haejin In
      Journal of Gastrointestinal Cancer.2022; 53(1): 170.     CrossRef
    • Re-do Operation Using a Robotic System due to Locoregional Recurrence after Initial Thyroidectomy for Thyroid Cancer
      Dong Gyu Kim, Kwangsoon Kim, Ji-Eun Lee, Joon Ho, Jin Kyong Kim, Sang-Wook Kang, Jandee Lee, Jong Ju Jeong, Kee-Hyun Nam, Woong Youn Chung
      Scientific Reports.2022;[Epub]     CrossRef
    • Patterns of Regional Failure after Pancreaticoduodenectomy in Patients with Distal Extrahepatic Cholangiocarcinoma: Suggestion of the Clinical Target Volume for Elective Nodal Irradiation
      W. Jung, Y. Park, K. Kim, H.J. Park, B.H. Kim
      Clinical Oncology.2022; 34(1): e45.     CrossRef
    • Dehydroevodiamine inhibits lung metastasis by suppressing survival and metastatic abilities of colorectal cancer cells
      Hee Dong Jeon, Yo-Han Han, Jeong-Geon Mun, Dae Hwan Yoon, Yeong Gyeong Lee, Ji-Ye Kee, Seung-Heon Hong
      Phytomedicine.2022; 96: 153809.     CrossRef
    • Cause-specific mortality rate of ovarian cancer in the presence of competing risks of death: a nationwide population-based cohort study
      Seung-Hyuk Shim, Myong Cheol Lim, Dahhay Lee, Young-Joo Won, Hyeong In Ha, Ha Kyun Chang, Hyunsoon Cho
      Journal of Gynecologic Oncology.2022;[Epub]     CrossRef
    • Comparative performance of various human papillomavirus assays available in Korea for detecting cervical intraepithelial neoplasia
      Yung‐Taek Ouh, Ji Jeong Park, Minjoo Kang, Miseon Kim, Jae Yun Song, So Jin Shin, Seung‐Hyuk Shim, Heon Jong Yoo, Maria Lee, Sung‐Jong Lee, Whan Shin, Gun Oh. Chong, Min Chul Choi, Chel Hun Choi, Kyung‐Jin Min
      Journal of Obstetrics and Gynaecology Research.2022; 48(1): 207.     CrossRef
    • Structural and functional brain alterations associated with cancer‐associated cognitive decline in gastric cancer patients: A preliminary longitudinal neuroimaging study
      Jaeun Ahn, DeokJong Lee, Young‐Chul Jung, Kyung Ran Kim
      Brain and Behavior.2022;[Epub]     CrossRef
    • Multifocal Organoid Capturing of Colon Cancer Reveals Pervasive Intratumoral Heterogenous Drug Responses
      Soon‐Chan Kim, Ji Won Park, Ha‐Young Seo, Minjung Kim, Jae‐Hyeon Park, Ga‐Hye Kim, Ja Oh Lee, Young‐Kyoung Shin, Jeong Mo Bae, Bon‐Kyoung Koo, Seung‐Yong Jeong, Ja‐Lok Ku
      Advanced Science.2022;[Epub]     CrossRef
    • Characterization of focal hypermetabolic thyroid incidentaloma: An analysis with F-18 fluorodeoxyglucose positron emission tomography/computed tomography parameters
      Haejun Lee, Yoo Seung Chung, Joon-Hyop Lee, Ki-Young Lee, Kyung-Hoon Hwang
      World Journal of Clinical Cases.2022; 10(1): 155.     CrossRef
    • Indications and outcomes of palliative major amputation in patients with metastatic cancer
      Christa L. LiBrizzi, Adam S. Levin, Sophia A. Strike, Carol D. Morris
      Surgical Oncology.2022; 40: 101700.     CrossRef
    • Impact of General Factors on Glioma Immunotherapy
      Qilin Huang, Dongmei Wang, Guojie Yao, Hongxiang Wang
      Journal of Clinical Neurology.2022; 18(1): 3.     CrossRef
    • Ramucirumab plus paclitaxel as a second-line treatment in HER2-positive gastric cancer: subgroup analysis of a nationwide, real-world study in Korea (KCSG-ST19-16)
      Bum Jun Kim, Hee-Jung Jee, Sun Young Rha, Hye Sook Han, Min-Hee Ryu, Se Hoon Park, Jong Gwang Kim, Woo Kyun Bae, Keun-Wook Lee, Do-Youn Oh, Ji-Hye Byun, Dong Sook Kim, Young Ju Suh, Hyonggin An, Dae Young Zang
      Gastric Cancer.2022; 25(3): 609.     CrossRef
    • Successful treatment of locally advanced bulky cervical cancer complicated by irreducible complete uterine prolapse
      Dong Hyung Lee, Jong Kil Joo, Dong Soo Suh, Byung Sup Shin, Seo Yoon Hwang, Ki Hyung Kim
      Medicine.2022; 101(3): e28664.     CrossRef
    • Current Status of Lung Cancer and Surgery Based on Studies Using a Nationwide Database
      Dohun Kim, Jung-Won Lee
      Journal of Chest Surgery.2022; 55(1): 1.     CrossRef
    • Prognostic Impact of Postoperative Complications in High-Risk Operable Non-small Cell Lung Cancer
      Seungwook Lee, Md Roknuggaman, Jung A Son, Seungji Hyun, Joonho Jung, Seokjin Haam, Woo Sik Yu
      Journal of Chest Surgery.2022; 55(1): 20.     CrossRef
    • Lipid-lowering drug adherence and combination therapy effects on gastrointestinal cancer in patients with dyslipidemia without diabetes: a retrospective cohort study in South Korea
      Kyu-Tae Han, Seungju Kim
      BMC Cancer.2022;[Epub]     CrossRef
    • HER2 Aberrations as a Novel Marker in Advanced Biliary Tract Cancer
      Hongsik Kim, Ryul Kim, Hye Ryeon Kim, Hyunji Jo, Hana Kim, Sang Yun Ha, Joon Oh Park, Young Suk Park, Seung Tae Kim
      Frontiers in Oncology.2022;[Epub]     CrossRef
    • Hypofractionated Radiotherapy for Early-Stage Breast Cancer: A Propensity Score Matched Analysis
      Anbok Lee, Hee Yeon Kim, Tae Hyun Kim, Ki Jung Ahn, Heunglae Cho, Sung Kwang Park, Yunseon Choi
      Journal of Korean Medical Science.2022;[Epub]     CrossRef
    • Conditional relative survival of patients with endometrial cancer: a Korean National Cancer Registry study
      Dong Wook Shin, Kyu-Won Jung, Johyun Ha, Jaeman Bae
      Journal of Gynecologic Oncology.2022;[Epub]     CrossRef
    • Trends in cervical cancer screening rates among Korean women: results of the Korean National Cancer Screening Survey, 2005–2020
      Hye Young Shin, Yun Yeong Lee, Soo Yeon Song, Bomi Park, Mina Suh, Kui Son Choi, Jae Kwan Jun
      Journal of Gynecologic Oncology.2022;[Epub]     CrossRef
    • Korean Surgical Practice Guideline for Pancreatic Cancer 2022: A summary of evidence-based surgical approaches
      Seung Eun Lee, Sung-Sik Han, Chang Moo Kang, Wooil Kwon, Kwang Yeol Paik, Ki Byung Song, Jae Do Yang, Jun Chul Chung, Chi-Young Jeong, Sun-Whe Kim
      Annals of Hepato-Biliary-Pancreatic Surgery.2022; 26(1): 1.     CrossRef
    • Expression of Spermine Oxidase Is Associated with Colorectal Carcinogenesis and Prognosis of Patients
      Sooyoun Kim, Doyeon Kim, Sanghyun Roh, Inpyo Hong, Hyeongjoo Kim, Tae Sung Ahn, Dong Hyun Kang, Moon Soo Lee, Moo-Jun Baek, Hyoung Jong Kwak, Chang-Jin Kim, Dongjun Jeong
      Biomedicines.2022; 10(3): 626.     CrossRef
    • A Pilot Feasibility Study of a Combined Supervised- and Home-Based Exercise to Improve Cancer-Related Symptoms in 1-3 Colorectal Cancer Patients
      Ji-Yong Byeon, Dong-Hyuk Park, Mi-Kyung Lee, Su Jin Yeon, Sun Ha Jee, Nam Kyu Kim, Tae Il Kim, Ji Soo Park, Justin Y. Jeon
      Exercise Science.2022; 31(1): 141.     CrossRef
    • Exposure to Secondhand Smoke and a Tobacco-Specific Carcinogen in Non-Smokers
      Jae-woo Lee, Woojung Yang, Ye-Seul Kim, Yonghwan Kim, Hyo-Sun Yoo, Hee-Taik Kang
      Korean Journal of Family Medicine.2022; 43(2): 117.     CrossRef
    • Dietary methyl donor nutrients, DNA mismatch repair polymorphisms, and risk of colorectal cancer based on microsatellite instability status
      Jimi Kim, Jeonghee Lee, Jae Hwan Oh, Dae Kyung Sohn, Aesun Shin, Jeongseon Kim, Hee Jin Chang
      European Journal of Nutrition.2022; 61(6): 3051.     CrossRef
    • The longitudinal effects of chronotype on chemotherapy-induced nausea and vomiting in patients with breast cancer receiving neoadjuvant chemotherapy
      Sanghyup Jung, Kyung-Lak Son, Saim Jung, Jung Yoon Moon, Gyu Han Oh, Chan-Woo Yeom, Kwang-Min Lee, Won-Hyoung Kim, Dooyoung Jung, Tae-Yong Kim, Seock-Ah Im, Kyung-Hun Lee, David Spiegel, Bong-Jin Hahm
      Journal of Psychosomatic Research.2022; 157: 110804.     CrossRef
    • Cancer Burden in China during 1990–2019: Analysis of the Global Burden of Disease
      Shu-Zhen Zhang, Li Zhang, Long Xie, Nadeem Sheikh
      BioMed Research International.2022;[Epub]     CrossRef
    • Prolonged or Transition to Metabolically Unhealthy Status, Regardless of Obesity Status, Is Associated with Higher Risk of Cardiovascular Disease Incidence and Mortality in Koreans
      Juhee Lee, So-Young Kwak, Dahyun Park, Ga-Eun Kim, Clara Yongjoo Park, Min-Jeong Shin
      Nutrients.2022; 14(8): 1644.     CrossRef
    • Global guidelines for breast cancer screening: A systematic review
      Wenhui Ren, Mingyang Chen, Youlin Qiao, Fanghui Zhao
      The Breast.2022; 64: 85.     CrossRef
    • A seven-autophagy-related gene signature for predicting the prognosis of differentiated thyroid carcinoma
      Chengxin Li, Qianqian Yuan, Gaoran Xu, Qian Yang, Jinxuan Hou, Lewei Zheng, Gaosong Wu
      World Journal of Surgical Oncology.2022;[Epub]     CrossRef
    • Fragmentation of care and colorectal cancer survival in South Korea: comparisons according to treatment at multiple hospitals
      Dong-Woo Choi, Seungju Kim, Dong Wook Kim, Kyu-Tae Han
      Journal of Cancer Research and Clinical Oncology.2022; 148(9): 2323.     CrossRef
    • Introducing the Sanguis-Filum for Detection of Gastric Mucosal Lesions Prior to Endoscopy: A Study Protocol
      Violet Kayamba, Paul Kelly
      Diagnostics.2022; 12(5): 1160.     CrossRef
    • Clinicopathologic and genomic characteristics of mucinous gastric adenocarcinoma
      Jae Eun Lee, Yoon Young Choi, Ji Yeong An, Ki Tae Kim, Su-Jin Shin, Jae-Ho Cheong
      Gastric Cancer.2022; 25(4): 697.     CrossRef
    • Immune Profile of BRAF-Mutated Metastatic Colorectal Tumors with Good Prognosis after Palliative Chemotherapy
      Jeong Eun Kim, Ji-Hun Kim, Sang-Yeob Kim, Hyungwoo Cho, Yeon-Mi Ryu, Yong Sang Hong, Sun Young Kim, Tae Won Kim
      Cancers.2022; 14(10): 2383.     CrossRef
    • Paradigm Shift in Prostate Cancer Diagnosis: Pre-Biopsy Prostate Magnetic Resonance Imaging and Targeted Biopsy
      Jung Jae Park, Chan Kyo Kim
      Korean Journal of Radiology.2022; 23(6): 625.     CrossRef
    • Risk factors and economic burden of postoperative anastomotic leakage related events in patients who underwent surgeries for colorectal cancer
      Jeonghyun Kang, Hyesung Kim, HyeJin Park, Bora Lee, Kang Young Lee, Alberto Meyer
      PLOS ONE.2022; 17(5): e0267950.     CrossRef
    • Factors Related to the Caregiving Burden on Families of Korean Patients With Lung Cancer
      Hyun Jung Lee, Soo Kyung Park
      Clinical Nursing Research.2022; 31(6): 1124.     CrossRef
    • Growth Pattern of Hepatic Metastasis as a Prognostic Index Reflecting Liver Metastasis-Associated Survival in Breast Cancer Liver Metastasis
      Jieun Lee, Moonhyung Choi, Seungyeon Joe, Kabsoo Shin, Sung-Hak Lee, Ahwon Lee
      Journal of Clinical Medicine.2022; 11(10): 2852.     CrossRef
    • Current Status of the National Health Screening Programs in South Korea
      Hee-Taik Kang
      Korean Journal of Family Medicine.2022; 43(3): 168.     CrossRef
    • Discovery of BRCA1/BRCA2 founder variants by haplotype analysis
      Won Kyung Kwon, Hyeok-Jae Jang, Jeong Eon Lee, Yeon Hee Park, Jai Min Ryu, Jonghan Yu, Ja-Hyun Jang, Jong-Won Kim
      Cancer Genetics.2022; 266-267: 19.     CrossRef
    • Prognostic Role of Systemic Inflammatory Markers in Patients Undergoing Surgical Resection for Oral Squamous Cell Carcinoma
      Uiju Cho, Yeoun-Eun Sung, Min-Sik Kim, Youn-Soo Lee
      Biomedicines.2022; 10(6): 1268.     CrossRef
    • Update of the Diagnostic and Therapeutic Role of the Pelvic Lymph Node Dissection Boundaries During Radical Cystectomy in Muscle Invasive Bladder Cancer
      Whi-An Kwon, Ho Kyung Seo
      The Korean Journal of Urological Oncology.2022; 20(2): 71.     CrossRef
    • Enhanced Recovery After Surgery Program for Radical Cystectomy
      Whi-An Kwon, Ho Kyung Seo
      The Korean Journal of Urological Oncology.2022; 20(2): 92.     CrossRef
    • Colon cancer organoids using monoclonal organoids established in four different lesions of one cancer patient reveal tumor heterogeneity and different real-time responsiveness to anti-cancer drugs
      Myoung-Hyun Song, Ji Won Park, Min Jung Kim, Young-Kyoung Shin, Soon-Chan Kim, Seung-Yong Jeong, Ja-Lok Ku
      Biomedicine & Pharmacotherapy.2022; 152: 113260.     CrossRef
    • Impact of the ACOSOG Z0011 trial on surgical practice in Asian patients: trends in axillary surgery for breast cancer from a Korean Breast Cancer Registry analysis
      Chihwan Cha, Eun Young Kim, Sung Yong Kim, Jai Min Ryu, Min Ho Park, Seokwon Lee, Young-jin Suh, Nayeon Choi, Hanpyo Hong, Hyung Suk Kim, Min Sung Chung
      World Journal of Surgical Oncology.2022;[Epub]     CrossRef
    • Various types of reconstruction after pancreaticoduodenectomy for the patients who underwent all types of gastrectomy: a single-enter experience
      Hyun-Jeong Jeon, Hyung-Jun Kwon, Yoon-Jin Hwang, Sang Geol Kim
      Annals of Surgical Treatment and Research.2022; 102(6): 323.     CrossRef
    • The T Category of Distal Extrahepatic Bile Duct Carcinoma
      Sun-Young Jun, Jae Hoon Shin, Jihyun Chun, Hyo Jeong Kang, Seung-Mo Hong
      American Journal of Surgical Pathology.2022; 46(7): 907.     CrossRef
    • Relationship between Health Behaviors and Metabolic Syndrome in Cancer Survivors in Korea: Korean National Health and Nutrition Examination Survey, 2013–2018
      Nayoung Kim, Seohwan Kim, Bong Gyu Choi, Yong Uk Ko, Kyoung ah Park
      Korean Journal of Family Practice.2022; 12(3): 144.     CrossRef
    • Utility of a deep learning model and a clinical model for predicting bleeding after endoscopic submucosal dissection in patients with early gastric cancer
      Ji Eun Na, Yeong Chan Lee, Tae Jun Kim, Hyuk Lee, Hong-Hee Won, Yang Won Min, Byung-Hoon Min, Jun Haeng Lee, Poong-Lyul Rhee, Jae J Kim
      World Journal of Gastroenterology.2022; 28(24): 2721.     CrossRef
    • Dyslipidemia Risk in Thyroid Cancer Patients: A Nationwide Population-Based Cohort Study
      Youhyun Song, Hye Sun Lee, Goeun Park, Sang-Wook Kang, Ji Won Lee
      Frontiers in Endocrinology.2022;[Epub]     CrossRef
    • Health Care Utilization and Anti-Cancer Drug Expenditure for Six Solid Cancers in Korea From 2007 to 2019
      Juhee Park, Kyeongjun Moon, Dong-Sook Kim
      Frontiers in Oncology.2022;[Epub]     CrossRef
    • Gynecologic cancer clinical practice guidelines in Korea and current issues
      Jeeyeon Kim, Joo-Hyuk Son, Tae-Wook Kong, Suk-Joon Chang
      Korean Journal of Women Health Nursing.2022; 28(2): 83.     CrossRef
    • Catching Up with the World: Pepsinogen Screening for Gastric Cancer in the United States
      Margaret J. Zhou, Robert J. Huang
      Cancer Epidemiology, Biomarkers & Prevention.2022; 31(7): 1257.     CrossRef
    • Trend Analysis and Prediction of Hepatobiliary Pancreatic Cancer Incidence and Mortality in Korea
      Hyeong Min Park, Young-Joo Won, Mee Joo Kang, Sang-Jae Park, Sun-Whe Kim, Kyu-Won Jung, Sung-Sik Han
      Journal of Korean Medical Science.2022;[Epub]     CrossRef
    • Application of the theory of planned behavior to understand physical activity intentions and behavior among Korean breast cancer survivors
      Jihee Min, Ye-Won Yu, Jeongmin Lee, Sujin Yeon, Ha-Nui Park, Joon Sung Lee, Kerry S. Courneya, Hyung Seok Park, Seung Il Kim, Justin Y. Jeon
      Supportive Care in Cancer.2022; 30(11): 8885.     CrossRef
    • Selection Strategies and Practical Application of BRAF V600E-Mutated Non–Small Cell Lung Carcinoma
      Inwoo Hwang, Yoon-La Choi, Hyunwoo Lee, Soohyun Hwang, Boram Lee, Hobin Yang, Chaithanya Chelakkot, Joungho Han
      Cancer Research and Treatment.2022; 54(3): 782.     CrossRef
    • Trends in the Performance of the Korean National Cancer Screening Program for Gastric Cancer from 2007 to 2016
      Ji Eun Ryu, Eunji Choi, Kyeongmin Lee, Jae Kwan Jun, Mina Suh, Kyu Won Jung, Kui Son Choi
      Cancer Research and Treatment.2022; 54(3): 842.     CrossRef
    • CT-Only Radiotherapy: An Exploratory Study for Automatic Dose Prediction on Rectal Cancer Patients Via Deep Adversarial Network
      Jiaqi Cui, Zhengyang Jiao, Zhigong Wei, Xiaolin Hu, Yan Wang, Jianghong Xiao, Xingchen Peng
      Frontiers in Oncology.2022;[Epub]     CrossRef
    • Expression of miR-221 and miR-18a in patients with hepatocellular carcinoma and its clinical significance
      Jong Hyuk Yun, Moo-Jun Baek, Hae Il Jung
      Korean Journal of Clinical Oncology.2022; 18(1): 17.     CrossRef
    • PEG‐rhG‐CSF for prophylaxis of neutropenia after chemotherapy in patients with non–small cell lung cancer: A multicenter, prospective, randomized study
      Xu‐Sheng Sun, Zhe Wang, Shu‐Hua Ren, He‐Lin Zhang, Li‐Jun Liu, Hong‐Bo Du, Xiao‐Wei Liu, Jun‐Feng Liu
      Thoracic Cancer.2022; 13(17): 2429.     CrossRef
    • Prognostic Impact of Neutropenia in Cancer Patients with Septic Shock: A 2009–2017 Nationwide Cohort Study
      Sang-Min Kim, Youn-Jung Kim, Ye-Jee Kim, Won-Young Kim
      Cancers.2022; 14(15): 3601.     CrossRef
    • Tearing down the barriers to exercise after mastectomy: a qualitative inquiry to facilitate exercise among breast cancer survivors
      Sujin Yeon, Ansuk Jeong, Jihee Min, Jiyong Byeon, Yong Jin Yoon, Jinmoo Heo, Chulwon Lee, Jeeye Kim, Seho Park, Seung Il Kim, Justin Y Jeon
      BMJ Open.2022; 12(7): e055157.     CrossRef
    • A Comparative Analysis of Patient Satisfaction and Cosmetic Outcomes after Breast Reconstruction through BREAST-Q and the Judgment of Medical Panels: Does it Reflect Well in Terms of Aesthetics in Korean Patients?
      Woo Jung Choi, Woo Jin Song, Sang Gue Kang
      Archives of Plastic Surgery.2022; 49(04): 488.     CrossRef
    • The Medical Needs and Characteristics of Cancer and Progressive Neurologic Disease Patients Who Use Home-Based Medical Care in Korea: A Retrospective Study for 2011-2020
      Yo Han Han, Shin Hye Yoo, Sun Young Lee, In Young Hwang, Kyae Hyung Kim, Belong Cho, Min Sun Kim, Wonho Choi, Yejin Kim
      Journal of the American Medical Directors Association.2022; 23(10): 1634.     CrossRef
    • Cognitive impairment in women newly diagnosed with thyroid cancer before treatment
      Mi Sook Jung, Moira Visovatti, Mijung Kim, Kyengin Cha, Nondumiso Dlamini, Xirong Cui
      Supportive Care in Cancer.2022; 30(11): 8959.     CrossRef
    • Survival trends in gastric cancer patients between 1987 and 2016: a population-based cohort study in Finland
      Urgena Maharjan, Joonas H. Kauppila
      Gastric Cancer.2022; 25(6): 989.     CrossRef
    • Clinical assessment of T2 papillary thyroid carcinoma: a retrospective study conducted at a single tertiary institution
      Hyesung Kim, Kwangsoon Kim, Ja Seong Bae, Jeong Soo Kim
      Scientific Reports.2022;[Epub]     CrossRef
    • Smoking trajectory and cancer risk: A population-based cohort study
      Minh Luu, Minji Han, Tra Bui, Phuong Thao Tran, Min-Kyung Lim, Jin Oh
      Tobacco Induced Diseases.2022; 20(August): 1.     CrossRef
    • Association of menopausal hormone therapy with gastric and colorectal cancer risks in Korean women: A nationwide population-based cohort study
      Chaewon Baek, Ji-Eun Kim, Aesun Shin, Ji-Yeob Choi
      Maturitas.2022; 166: 35.     CrossRef
    • Decreased Preoperative Serum AGR as a Diagnostic Marker of Poor Prognosis after Radical Surgery of Upper Urinary Tract and Bladder Cancers from a Pooled Analysis of 9,002 Patients
      Xiaoyan Wang, Guodong Yang, Yumeng Chai, Zhouyue Li, Xuanyan Che, Yongqiang Wang, Liqing Yang, Zhongbao Zhou, Zhongjie Shi
      Disease Markers.2022; 2022: 1.     CrossRef
    • Effect of Helicobacter pylori infection and its eradication on the expression of tight junction proteins in the gastric epithelium in relation to gastric carcinogenesis
      SooIn Choi, Nayoung Kim, Ji Hyun Park, Ryoung Hee Nam, Chin‐Hee Song, Hye Seung Lee
      Helicobacter.2022;[Epub]     CrossRef
    • Efficacy of an Integrated Mobile Application System for Patients with Radiation Therapy: A Pilot Study
      Jaehyeon Park, Ji Woon Yea, Se An Oh, Jae Won Park
      Healthcare.2022; 10(9): 1696.     CrossRef
    • Safety of performing distal pancreatosplenectomy in patients who underwent distal gastrectomy previously: a multicenter cohort analysis with systematic literature review
      Sung Eun Park, Kwang Yeol Paik, Dong Do You, Tae Yoon Lee, Kee-Hwan Kim, Gun Hyung Na, Jung Hyun Park, Tae Ho Hong
      Annals of Surgical Treatment and Research.2022; 103(3): 145.     CrossRef
    • Clinical Significance of Tumor Size in Gross Extrathyroidal Extension to Strap Muscles (T3b) in Papillary Thyroid Carcinoma: Comparison with T2
      Joonseon Park, Il Ku Kang, Ja Seong Bae, Jeong Soo Kim, Kwangsoon Kim
      Cancers.2022; 14(19): 4615.     CrossRef
    • Identification of Biomarkers Associated with Liver Metastasis Progression from Colorectal Cancer Using Exosomal RNA Profiling
      Soohyeon Lee, Young Soo Park, Jwa Hoon Kim, Ah Reum Lim, Myung Han Hyun, Boyeon Kim, Jong Won Lee, Saet Byeol Lee, Yeul Hong Kim
      Cancers.2022; 14(19): 4723.     CrossRef
    • Fear of Cancer Recurrence and Its Negative Impact on Health-Related Quality of Life in Long-term Breast Cancer Survivors
      Thi Xuan Mai Tran, So-Youn Jung, Eun-Gyeong Lee, Heeyoun Cho, Na Yeon Kim, Sungkeun Shim, Ho Young Kim, Danbee Kang, Juhee Cho, Eunsook Lee, Yoon Jung Chang, Hyunsoon Cho
      Cancer Research and Treatment.2022; 54(4): 1065.     CrossRef
    • Disparities in All-Cause Mortality in Older Patients with Colorectal Cancer According to Disability Status: A Nationwide Analysis
      Woo-Ri Lee, Kyu-Tae Han, Mingee Choi, Woorim Kim
      Current Oncology.2022; 29(10): 7430.     CrossRef
    • RNA m5C regulator-mediated modification patterns and the cross-talk between tumor microenvironment infiltration in gastric cancer
      Qiang Zhang, Xiangfei Sun, Jianyi Sun, Jiangshen Lu, Xiaodong Gao, Kuntang Shen, Xinyu Qin
      Frontiers in Immunology.2022;[Epub]     CrossRef
    • Association between serum ferritin levels and colorectal cancer risk in Korea
      Hyunho Kim, Kyungdo Han, Seung-Hyun Ko, Ho Jung An
      The Korean Journal of Internal Medicine.2022; 37(6): 1205.     CrossRef
    • Diagnostic distribution and pitfalls of glandular abnormalities in cervical cytology: a 25-year single-center study
      Jung-A Sung, Ilias P. Nikas, Haeryoung Kim, Han Suk Ryu, Cheol Lee
      Journal of Pathology and Translational Medicine.2022; 56(6): 354.     CrossRef
    • Body Compositions of Elderly and Non-Elderly Patients Following Gastrectomy for Gastric Cancer
      Ji Hoon Kang, Mi Ran Jung, Sung Eun Kim, Oh Jeong
      Annals of Clinical Nutrition and Metabolism.2022; 14(2): 81.     CrossRef
    • A Systematic Review of Economic Evaluation of Thyroid Cancer
      Mijin Kim, Woojin Lim, Kyungsik Kim, Ja Seong Bae, Byung Joo Lee, Bon Seok Koo, Eun Kyung Lee, Eu Jeong Ku, June Young Choi, Bo Hyun Kim, Sue K. Park
      International Journal of Thyroidology.2022; 15(2): 74.     CrossRef
    • Prediction of Radiotherapy Compliance in Elderly Cancer Patients Using an Internally Validated Decision Tree
      Biche Osong, Inigo Bermejo, Kyu Chan Lee, Seok Ho Lee, Andre Dekker, Johan van Soest
      Cancers.2022; 14(24): 6116.     CrossRef
    • Status of Endoscopic Screening Strategies for Upper Gastrointestinal Tract Cancer
      Bin Lyu, Xiao-Liang Jin
      Cancer Screening and Prevention.2022; 000(000): 000.     CrossRef
    • Efficacy of a 4-Week Nurse-Led Exercise Rehabilitation Program in Improving the Quality of Life in Women Receiving a Post-Mastectomy Reconstruction Using the Motiva ErgonomixTM Round SilkSurface
      Jung Joong Kang, Hyunho Lee, Bom Hui Park, Yu Kwan Song, Soon Eun Park, Robert Kim, Kyung Ah Lee
      International Journal of Environmental Research and Public Health.2022; 20(1): 16.     CrossRef
    • Clinical utilization of radiation therapy in Korea between 2017 and 2019
      Eunji Kim, Won Il Jang, Kwangmo Yang, Mi-Sook Kim, Hyung Jun Yoo, Eun Kyung Paik, Heejin Kim, Jaesun Yoon
      Radiation Oncology Journal.2022; 40(4): 251.     CrossRef
    • Effect of Pap smears on the long-term survival of cervical cancer patients: a nationwide population-based cohort study in Korea
      Xuan Quy Luu, Kyeongmin Lee, Jae Kwan Jun, Mina Suh, kyu-won Jung, Myong Cheol Lim, Kui Son Choi
      Epidemiology and Health.2022; 44: e2022072.     CrossRef
    • Clinical Spectrum of Uveal Metastasis in Korean Patients Based on Primary Tumor Origin
      Hyun Goo Kang, Minha Kim, Suk Ho Byeon, Sung Soo Kim, Hyoung Jun Koh, Sung Chul Lee, Min Kim
      Ophthalmology Retina.2021; 5(6): 543.     CrossRef
    • Environmental exposure to cadmium and risk of thyroid cancer from national industrial complex areas: A population-based cohort study
      Eunjung Park, Seyoung Kim, Sang-Hwan Song, Chul-Woo Lee, Jung-Taek Kwon, Min Kyung Lim, Eun Young Park, Young-Joo Won, Kyu-Won Jung, Byungmi Kim
      Chemosphere.2021; 268: 128819.     CrossRef
    • Conditional relative survival of cervical cancer: a Korean National Cancer Registry Study
      Dong Wook Shin, Jaeman Bae, Johyun Ha, Kyu-Won Jung
      Journal of Gynecologic Oncology.2021;[Epub]     CrossRef
    • Trend analysis of process quality indicators for the Korean National Cervical Cancer Screening Program from 2005 to 2013
      Cam Nhung Bui, Eunji Choi, Mina Suh, Jae Kwan Jun, Kyu Won Jung, Myong Cheol Lim, Kui Son Choi
      Journal of Gynecologic Oncology.2021;[Epub]     CrossRef
    • Changes after cancer diagnosis and return to work: experience of Korean cancer patients
      Ka Ryeong Bae, Juhee Cho
      BMC Cancer.2021;[Epub]     CrossRef
    • Korean colonoscopy screening pilot study (K-cospi) for screening colorectal cancer: study protocol for the multicenter, community-based clinical trial
      Bomi Park, Jae Kwan Jun, Byung Chang Kim, Kui Son Choi, Mina Suh, Young Sun Kim, Tae Il Kim, Eun-Cheol Park, Dae Kyung Sohn, JinHee Sohn, Eui Gon Youk, Woong Ki Chang, Byung Ik Jang, Seung-Yong Jeong, Jae Myung Cha, Jae Yong Han, Byung Chang Kim, Hyun Soo
      BMC Gastroenterology.2021;[Epub]     CrossRef
    • Clinical analysis of the patients with osseous metastatic breast cancer
      Hyung-Seok Park, Yong Jin Cho
      Medical Biological Science and Engineering.2021; 4(1): 27.     CrossRef
    • Machine Learning Approach to Predict the Probability of Recurrence of Renal Cell Carcinoma After Surgery: Prediction Model Development Study
      HyungMin Kim, Sun Jung Lee, So Jin Park, In Young Choi, Sung-Hoo Hong
      JMIR Medical Informatics.2021; 9(3): e25635.     CrossRef
    • Conditional Relative Survival and Competing Mortality of Patients with Prostate Cancer in Korea: A Nationwide Cohort Study
      Jinsung Park, Kyungdo Han, Dong Wook Shin, Sang Hyun Park, Hyun Bin Shin
      Cancer Epidemiology, Biomarkers & Prevention.2021; 30(2): 326.     CrossRef
    • MicroRNA Profile for Diagnostic and Prognostic Biomarkers in Thyroid Cancer
      Jong-Lyul Park, Seon-Kyu Kim, Sora Jeon, Chan-Kwon Jung, Yong-Sung Kim
      Cancers.2021; 13(4): 632.     CrossRef
    • Use of budget savings from patent expiration of cancer drugs to improve affordability and accessibility
      Seung Mi Lee, Heui Jae Kim, David Suh, Kyung-In Joung, Eun Suk Kim, Hee Jung Back, Jun Young Kwon, Man-Jae Park, Dong Churl Suh
      BMC Health Services Research.2021;[Epub]     CrossRef
    • Updated Trends in Cancer in Japan: Incidence in 1985–2015 and Mortality in 1958–2018—A Sign of Decrease in Cancer Incidence
      Kota Katanoda, Megumi Hori, Eiko Saito, Akiko Shibata, Yuri Ito, Tetsuji Minami, Sayaka Ikeda, Tatsuya Suzuki, Tomohiro Matsuda
      Journal of Epidemiology.2021; 31(7): 426.     CrossRef
    • Short and Long-Term Mortality Trends for Cancer Patients with Septic Shock Stratified by Cancer Type from 2009 to 2017: A Population-Based Cohort Study
      Youn-Jung Kim, Min-Ju Kim, Ye-Jee Kim, Won Young Kim
      Cancers.2021; 13(4): 657.     CrossRef
    • Applications of Artificial Intelligence in Mammography from a Development and Validation Perspective
      Ki Hwan Kim, Sang Hyup Lee
      Journal of the Korean Society of Radiology.2021; 82(1): 12.     CrossRef
    • Digital Mammography as a Screening Tool in Korea
      Soo Yeon Song, Seri Hong, Jae Kwan Jun
      Journal of the Korean Society of Radiology.2021; 82(1): 2.     CrossRef
    • Gastric Cancer Risk Prediction Using an Epidemiological Risk Assessment Model and Polygenic Risk Score
      Boyoung Park, Sarah Yang, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Jeongseon Kim
      Cancers.2021; 13(4): 876.     CrossRef
    • Different effects of p53 protein overexpression on the survival of gastric cancer patients according to Lauren histologic classification: a retrospective study
      Ki Wook Kim, Nayoung Kim, Yonghoon Choi, Won Seok Kim, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Dong Ho Lee, Young Suk Park, Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim, Hye Seung Lee, Ji-Won Kim, Jin Won Kim, Keun-Wook Lee, Won Chang, Ji Hoon Park, Yoon
      Gastric Cancer.2021; 24(4): 844.     CrossRef
    • Analysis of the tumor characteristics in young age breast cancer patients using collaborative stage data of the Korea Central Cancer Registry
      Junyup Kim, Seri Hong, Jae Jun Lee, Young-Joo Won, Eun Sook Lee, Han-Sung Kang, Seeyoun Lee, Jai Hong Han, Eun-Gyeong Lee, Heein Jo, Hyun Hee Kim, So-Youn Jung
      Breast Cancer Research and Treatment.2021; 187(3): 785.     CrossRef
    • Mechanisms of resistance to chemotherapy in non-small cell lung cancer
      Hye-Young Min, Ho-Young Lee
      Archives of Pharmacal Research.2021; 44(2): 146.     CrossRef
    • Recent progress in gastric cancer prevention
      Jin Young Park, Rolando Herrero
      Best Practice & Research Clinical Gastroenterology.2021; 50-51: 101733.     CrossRef
    • Palbociclib Plus Fulvestrant in Korean Patients from PALOMA-3 With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer
      Jee Hyun Kim, Seock-Ah Im, Sung Hoon Sim, Eustratios Bananis, Xin Huang, Hyun Seon Kim, Sung-Bae Kim
      Journal of Breast Cancer.2021; 24(1): 97.     CrossRef
    • Therapeutic Status and Available Strategies in Pancreatic Ductal Adenocarcinoma
      Gitika Thakur, Raj Kumar, Saet-Byul Kim, Sang-Yeob Lee, Sung-Lim Lee, Gyu-Jin Rho
      Biomedicines.2021; 9(2): 178.     CrossRef
    • Changes in Metabolic Syndrome Status and Breast Cancer Risk: A Nationwide Cohort Study
      In Young Choi, Sohyun Chun, Dong Wook Shin, Kyungdo Han, Keun Hye Jeon, Jonghan Yu, Byung Joo Chae, Mina Suh, Yong-Moon Park
      Cancers.2021; 13(5): 1177.     CrossRef
    • Comparing short-term outcomes after totally laparoscopic distal gastrectomy and laparoscopy-assisted distal gastrectomy with Billroth I anastomosis: early experience of a single institution
      Inhyuck Lee, Kwang Hee Kim, Sang Hyuk Seo, Min Sung An, HyungJoo Baik, Yo Han Park, Sang Hyun Kang, Sang Hoon Oh
      The Journal of Minimally Invasive Surgery.2021; 24(1): 26.     CrossRef
    • Association Rules of Comorbidities in Patients Hospitalized for Lung Cancer
      Sung-Soo Kim
      Journal of Health Informatics and Statistics.2021; 46(1): 100.     CrossRef
    • Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy
      Kyunghye Bang, Jaekyung Cheon, Jae Ho Jeong, Hyeon-Su Im, Kyu-pyo Kim, Baek-Yeol Ryoo, Changhoon Yoo
      Therapeutic Advances in Medical Oncology.2021;[Epub]     CrossRef
    • MicroRNA-552 expression in colorectal cancer and its clinicopathological significance
      Joon Im, Soo Kyung Nam, Hye Seung Lee
      Journal of Pathology and Translational Medicine.2021; 55(2): 125.     CrossRef
    • Forearm Muscle Activity Patterns during Open Thyroidectomy Using 8-Channel Surface Electromyography
      Yun Suk Choi, Hyun-jin Joo, Jong-Hyuk Ahn, Hyoun-Joong Kong, Jin Wook Yi
      Journal of Endocrine Surgery.2021; 21(1): 27.     CrossRef
    • Trastuzumab-based palliative chemotherapy for HER2-positive gastric cancer: a single-center real-world data
      Tae-Hwan Kim, Hun Do Cho, Yong Won Choi, Hyun Woo Lee, Seok Yun Kang, Geum Sook Jeong, Jin-Hyuk Choi, Mi Sun Ahn, Seung-Soo Sheen
      BMC Cancer.2021;[Epub]     CrossRef
    • Nutrient intakes from supplement and factors associated with supplement use among breast cancer survivors: A cross‐sectional study
      Jiyoung Youn, Sihyun Park, Sihan Song, Hyeong‐Gon Moon, Dong‐Young Noh, So‐Youn Jung, Eunsook Lee, Zisun Kim, Hyun Jo Youn, Jihyoung Cho, Young Bum Yoo, Se Kyung Lee, Taisun Hyun, Jung Eun Lee
      European Journal of Cancer Care.2021;[Epub]     CrossRef
    • Does Delaying Time in Cancer Treatment Affect Mortality? A Retrospective Cohort Study of Korean Lung and Gastric Cancer Patients
      Kyu-Tae Han, Woorim Kim, Seungju Kim
      International Journal of Environmental Research and Public Health.2021; 18(7): 3462.     CrossRef
    • Awareness and Use of Complementary and Alternative Medicine in Korean Lung Cancer Patients
      Joon Young Choi, Wonjun Ji, Chang-Min Choi, Chaeuk Chung, Jae Myoung Noh, Cheol-Kyu Park, In-Jae Oh, Hong In Yoon, Hyeong Ryul Kim, Ho Young Kim, Chang Dong Yeo, Seung Hun Jang
      Tuberculosis and Respiratory Diseases.2021; 84(2): 105.     CrossRef
    • Patterns of definitive radiotherapy practice for cervical cancer in South Korea: a survey endorsed by the Korean Radiation Oncology Group (KROG 20-06)
      Nalee Kim, Won Park
      Journal of Gynecologic Oncology.2021;[Epub]     CrossRef
    • Salvage proton beam therapy for locoregional recurrence of non-small cell lung cancer
      Hyunju Shin, Jae Myoung Noh, Hongryull Pyo, Yong Chan Ahn, Dongryul Oh
      Radiation Oncology Journal.2021; 39(1): 24.     CrossRef
    • A Case of Lymphocyte-Rich Hepatocellular Carcinoma in a Patient Who Was Treated for Colon Cancer
      Jae Won Song, Ho Soo Chun, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Young Nyun Park, Dai Hoon Han, Do Young Kim
      Journal of Liver Cancer.2021; 21(1): 69.     CrossRef
    • Nuclear Factor Erythroid 2-related Factor 2 Knockout Suppresses the Development of Aggressive Colorectal Cancer Formation Induced by Azoxymethane/Dextran Sulfate Sodium-Treatment in Female Mice
      Chin-Hee Song, Nayoung Kim, Ryoung Hee Nam, Soo In Choi, Changhee Kang, Jae Young Jang, Heewon Nho, Eun Shin, Ha-Na Lee
      Journal of Cancer Prevention.2021; 26(1): 41.     CrossRef
    • Prediction of Cancer Incidence and Mortality in Korea, 2021
      Kyu-Won Jung, Young-Joo Won, Seri Hong, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo
      Cancer Research and Treatment.2021; 53(2): 316.     CrossRef
    • The mediating effect of resilience on happiness of advanced lung cancer patients
      Sunwha Cho, Eunjung Ryu
      Supportive Care in Cancer.2021; 29(11): 6217.     CrossRef
    • Analysis of HPV Prevalence in Pairs of Cervical and Urine Samples from the Same Woman
      Dong Hyeok Kim, Hyunwoo Jin, Kyung Eun Lee
      Biomedical Science Letters.2021; 27(1): 28.     CrossRef
    • Second Primary Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancers after Breast Cancer Diagnosis: Korea Central Cancer Registry
      Hyeong In Ha, Eun-Gyeong Lee, Jiwon Lim, So-Youn Jung, Yoon Jung Chang, Young-Joo Won, Myong Cheol Lim
      Cancer Research and Treatment.2021; 53(2): 541.     CrossRef
    • Moderating Effect of Inner Strength between Mood Status and Quality of Life in Female Patients with Lung Cancer
      Young-En Lee, Eunjung Ryu
      Asian Oncology Nursing.2021; 21(1): 24.     CrossRef
    • Current Trends in the Quality Assessment of Colorectal Cancer Practice and Treatment in South Korea during 2012-2017
      Kyu Hye Choi, Jin Ho Song, Hong Seok Jang, Sung Hwan Kim, Jong Hoon Lee
      Cancer Research and Treatment.2021; 53(2): 487.     CrossRef
    • Implications of Radiotherapy Utilization in Korea from 2010 to 2019
      Jeongshim Lee, Woo Chul Kim, Won Sup Yoon, Chai Hong Rim
      Journal of Korean Medical Science.2021;[Epub]     CrossRef
    • The Effect of Body Mass Index on Initial Breast Cancer Stage Among Korean Women
      Yongwoong Lee, Eunyoung Kang, Hee-Chul Shin, Haemin Lee, Kyunghwak Yoon, Byeongju Kang, Eun-Kyu Kim
      Clinical Breast Cancer.2021; 21(6): e631.     CrossRef
    • Breast Cancer Statistics in Korea, 2018
      Sang Yull Kang, Sae Byul Lee, Yoo Seok Kim, Zisun Kim, Hyun Yul Kim, Hee Jeong Kim, Sungmin Park, Soo Youn Bae, Kwanghyun Yoon, Se Kyung Lee, Kyu-Won Jung, Jaihong Han, Hyun Jo Youn
      Journal of Breast Cancer.2021; 24(2): 123.     CrossRef
    • Do cholesterol levels and continuity of statin use affect colorectal cancer incidence in older adults under 75 years of age?
      Kyu-Tae Han, Seungju Kim, Antonio Palazón-Bru
      PLOS ONE.2021; 16(4): e0250716.     CrossRef
    • Risk of female-specific cancers according to obesity and menopausal status in 2•7 million Korean women: Similar trends between Korean and Western women
      In Sil Park, Se Ik Kim, Youngjin Han, Juhwan Yoo, Aeran Seol, HyunA Jo, Juwon Lee, Wenyu Wang, Kyungdo Han, Yong Sang Song
      The Lancet Regional Health - Western Pacific.2021; 11: 100146.     CrossRef
    • Detection of asymptomatic recurrence improves survival of gastric cancer patients
      Ji Soo Park, Eun‐Ah Choe, Sejung Park, Chung Mo Nam, Woo Jin Hyung, Sung Hoon Noh, Seoyoung Lee, Hyo Song Kim, Minkyu Jung, Hyun Cheol Chung, Sun Young Rha
      Cancer Medicine.2021; 10(10): 3249.     CrossRef
    • Clinical Implication of Liquid Biopsy in Colorectal Cancer Patients Treated with Metastasectomy
      Soohyeon Lee, Young-Soo Park, Won-Jin Chang, Jung Yoon Choi, Ahreum Lim, Boyeon Kim, Saet-Byeol Lee, Jong-Won Lee, Seon-Hahn Kim, Jin Kim, Jung-Myun Kwak, Kyung-Chul Yoon, Sung-Ho Lee, Yeul Hong Kim
      Cancers.2021; 13(9): 2231.     CrossRef
    • Chuna Manual Therapy for Lymphedema: A Systematic Review and Meta-analysis
      In-Che Chung, Ye-eun Kim, Jeong-hoon Ahn, In-sik Han, In-hwa Park, Yun-Yeop Cha
      Journal of Korean Medicine Rehabilitation.2021; 31(2): 15.     CrossRef
    • Population-based study on the association between autoimmune disease and lymphoma: National Health Insurance Service-National Sample Cohort 2002–2015 in Korea
      Jae Sik Kim, Il Han Kim, Ja Min Byun, Ji Hyun Chang
      Journal of Autoimmunity.2021; 121: 102647.     CrossRef
    • Anticancer Efficacy of Nonthermal Plasma Therapy Combined with PD-L1 Antibody Conjugated Gold Nanoparticles on Oral Squamous Cell Carcinoma
      Jinyoung Park, Yoon-Seo Jang, Jeong-Hae Choi, Miheon Ryu, Gyoo-Cheon Kim, June-Ho Byun, Dae-Seok Hwang, Uk-Kyu Kim
      Applied Sciences.2021; 11(10): 4559.     CrossRef
    • Korean clinical practice guideline for pancreatic cancer 2021: A summary of evidence-based, multi-disciplinary diagnostic and therapeutic approaches

      Pancreatology.2021; 21(7): 1326.     CrossRef
    • Incidence and Clinical Outcomes of Febrile Neutropenia in Adult Cancer Patients with Chemotherapy Using Korean Nationwide Health Insurance Database
      Dalyong Kim, Soohyeon Lee, Taemi Youk, Soojung Hong
      Yonsei Medical Journal.2021; 62(6): 479.     CrossRef
    • Long-term effect of simplified dietary education on the nutritional status of patients after a gastrectomy
      Kyeong-Won Ryu, Jae-Moon Bae, Eun-Mee Kim, Ji Yeong An, Min-Gew Choi, Jun Ho Lee, Tae Sung Sohn, Robert Jeenchen Chen
      PLOS ONE.2021; 16(5): e0252168.     CrossRef
    • Occupational radiation exposure and cancer incidence in a cohort of diagnostic medical radiation workers in South Korea
      Won Jin Lee, Seulki Ko, Ye Jin Bang, Seung-Ah Choe, Yeongchull Choi, Dale L Preston
      Occupational and Environmental Medicine.2021; 78(12): 876.     CrossRef
    • Endoscopic Screening and Surveillance for Gastric Cancer
      Bokyung Kim, Soo-Jeong Cho
      Gastrointestinal Endoscopy Clinics of North America.2021; 31(3): 489.     CrossRef
    • Metastatic gastric cancer of the testis diagnosed through urine cytology
      Mee Sook Roh, Song-Hee Han
      Journal of Pathology and Translational Medicine.2021; 55(4): 303.     CrossRef
    • Cervical Cancer-Associated Suffering: Estimating the Palliative Care Needs of a Highly Vulnerable Population
      Eric L. Krakauer, Xiaoxiao Kwete, Khadidjatou Kane, Gauhar Afshan, Lisa Bazzett-Matabele, Danta Dona Ruthnie Bien-Aimé, Sarah Byrne-Martelli, Stephen Connor, Raimundo Correa, C. R. Beena Devi, Mamadou Diop, Nahla Gafer, Annekathryn Goodman, Surbhi Grover,
      JCO Global Oncology.2021; (7): 862.     CrossRef
    • Association of Family History with the Development of Breast Cancer: A Cohort Study of 129,374 Women in KoGES Data
      Hyo Geun Choi, Jung Ho Park, Yeon Ju Choi, Yong Joon Suh
      International Journal of Environmental Research and Public Health.2021; 18(12): 6409.     CrossRef
    • Is time-to-treatment associated with higher mortality in Korean elderly lung cancer patients?
      Kyu-Tae Han, Woorim Kim, Areum Song, Yeong Jun Ju, Dong-Woo Choi, Seungju Kim
      Health Policy.2021; 125(8): 1047.     CrossRef
    • Patterns of Locoregional Recurrence after Radical Cystectomy for Stage T3-4 Bladder Cancer: A Radiation Oncologist's Point of View
      Hyun Ju Kim, Jaehee Chun, Tae Hyung Kim, Gowoon Yang, Sang Joon Shin, Jin Sung Kim, Jaemoon Yang, Won Sik Ham, Woong Sub Koom
      Yonsei Medical Journal.2021; 62(7): 569.     CrossRef
    • Factors to improve distress and fatigue in Cancer survivorship; further understanding through text analysis of interviews by machine learning
      Kyungmi Yang, Jina Kim, Mison Chun, Mi Sun Ahn, Eunae Chon, Jinju Park, Mijin Jung
      BMC Cancer.2021;[Epub]     CrossRef
    • Effectiveness of the Korean National Cancer Screening Program in reducing breast cancer mortality
      Eunji Choi, Jae Kwan Jun, Mina Suh, Kyu-Won Jung, Boyoung Park, Kyeongmin Lee, So-Youn Jung, Eun Sook Lee, Kui Son Choi
      npj Breast Cancer.2021;[Epub]     CrossRef
    • Relationship between Health Literacy and Self-care Behavior in Patients with Stomach Cancer after Gastrectomy: Mediating Effects of Subjective Health Status and Specific Self-efficacy
      Min Jung Kim, Yong Soon Shin
      Korean Journal of Adult Nursing.2021; 33(3): 259.     CrossRef
    • Changes in Korean National Healthcare Insurance Policy and Breast Cancer Surgery Trend in Korea
      Musaed Rayzah, Jai Min Ryu, Jun-Hee Lee, Seok Jin Nam, Seok Won Kim, Se Kyung Lee, Jonghan Yu, Kyeong-Tae Lee, Sa-Ik Bang, Goo-Hyun Mun, Jai-Kyong Pyon, Byung-Joon Jeon, Jeong Eon Lee
      Journal of Korean Medical Science.2021;[Epub]     CrossRef
    • Transcription factor PAX4 facilitates gastric cancer progression through interacting with miR-27b-3p/Grb2 axis
      Yan Zhang, Li Ding, Qingfeng Ni, Ran Tao, Jun Qin
      Aging.2021; 13(12): 16786.     CrossRef
    • Genetic Susceptibility of ACE2 and TMPRSS2 in Six Common Cancers and Possible Impacts on COVID-19
      Tung Hoang, Trung Quang Nguyen, Tho Thi Anh Tran
      Cancer Research and Treatment.2021; 53(3): 650.     CrossRef
    • Clinicopathologic features of cutaneous metastases from internal malignancies
      Hyeong Mok Kwon, Gyu Yeong Kim, Dong Hoon Shin, Young Kyung Bae
      Journal of Pathology and Translational Medicine.2021; 55(4): 289.     CrossRef
    • Brachytherapy utilization rate and effect on survival in cervical cancer patients in Korea
      Young Ae Kim, Min Soo Yang, Minae Park, Min Gee Choi, So Young Kim, Yeon-Joo Kim
      Journal of Gynecologic Oncology.2021;[Epub]     CrossRef
    • Prevalence of cancer susceptibility variants in patients with multiple Lynch syndrome related cancers
      Yoon Young Choi, Su-Jin Shin, Jae Eun Lee, Lisa Madlensky, Seung-Tae Lee, Ji Soo Park, Jeong-Hyeon Jo, Hyunki Kim, Daniela Nachmanson, Xiaojun Xu, Sung Hoon Noh, Jae-Ho Cheong, Olivier Harismendy
      Scientific Reports.2021;[Epub]     CrossRef
    • Expression of HER2 and Mismatch Repair Proteins in Surgically Resected Gallbladder Adenocarcinoma
      You-Na Sung, Sung Joo Kim, Sun-Young Jun, Changhoon Yoo, Kyu-Pyo Kim, Jae Hoon Lee, Dae Wook Hwang, Shin Hwang, Sang Soo Lee, Seung-Mo Hong
      Frontiers in Oncology.2021;[Epub]     CrossRef
    • Stepwise-Hierarchical Pooled Analysis for Synergistic Interpretation of Meta-analyses Involving Randomized and Observational Studies: Methodology Development
      In-Soo Shin, Chai Hong Rim
      Journal of Medical Internet Research.2021; 23(9): e29642.     CrossRef
    • Scoring model for discriminating gastric cancer risk in patients with negative serum pepsinogen and anti‐Helicobacter pylori antibody results
      Jun‐Hyung Cho, So‐Young Jin, Suyeon Park
      Journal of Gastroenterology and Hepatology.2021; 36(12): 3345.     CrossRef
    • Incidence and survival rates of lymphoepithelioma-like gastric carcinoma: analysis of the Korea Central Cancer Registry Database
      Jin-Woo Kim, Ji-Hoon Kim, Hee Man Kim
      Scandinavian Journal of Gastroenterology.2021; 56(10): 1182.     CrossRef
    • 3 Cases of Cancer Patients Whose Natural Killer Cell Activity Improved with Traditional Korean Medicine Treatment: A Case Series
      Chan-ran Park, Eun-ji Kim, Chang-gue Son, Jung-hyo Cho, Nam-hun Lee
      The Journal of Internal Korean Medicine.2021; 42(3): 444.     CrossRef
    • The prognostic value of the pretreatment serum albumin to globulin ratio for predicting adverse pathology in patients undergoing radical prostatectomy for prostate cancer
      Jae-Wook Chung, Yun-Sok Ha, Sang Won Kim, Seung Chol Park, Taek Won Kang, Young Beom Jeong, Sung-Woo Park, Jinsung Park, Eun Sang Yoo, Tae Gyun Kwon, Sung Pil Seo, Ho Won Kang, Won Tae Kim, Yong-June Kim, Sang-Cheol Lee, Wun-Jae Kim, Seok Joong Yun, Tae-H
      Investigative and Clinical Urology.2021; 62(5): 545.     CrossRef
    • Descriptive epidemiology of cancer of unknown primary in South Korea, 1999–2017
      Yoo-Kyung Boo, Dayeon Park, Jiwon Lim, Hyun-Sook Lim, Young-Joo Won
      Cancer Epidemiology.2021; 74: 102000.     CrossRef
    • Seasonal variations in the diagnosis of the top 10 cancers in Korea: A nationwide population‐based study using a common data model
      Jin Young Yoon, Min Seob Kwak, Ha Il Kim, Jae Myung Cha
      Journal of Gastroenterology and Hepatology.2021; 36(12): 3371.     CrossRef
    • Population-wide impacts of aspirin, statins, and metformin use on prostate cancer incidence and mortality
      Hye Yeon Koo, Su-Min Jeong, Mi Hee Cho, Sohyun Chun, Dong Wook Shin, Jinsung Park
      Scientific Reports.2021;[Epub]     CrossRef
    • Psychometric evaluation of patient assessment of chronic illness care among Korean cancer survivors
      Soo Hyun Kim, Bo Gyeong Lee, Yu Hyeon Choe, Francesca Chiesi
      PLOS ONE.2021; 16(8): e0256119.     CrossRef
    • A serial multiple mediator model of sense of coherence, coping strategies, depression, and quality of life among gynecologic cancer patients undergoing chemotherapy
      Hee Sun Kim, Ju-Hee Nho, Joo-Hyun Nam
      European Journal of Oncology Nursing.2021; 54: 102014.     CrossRef
    • Microsatellite Instability and Effectiveness of Adjuvant Treatment in pT1N1 Gastric Cancer: A Multicohort Study
      Namkee Oh, Hyunki Kim, Kyoung-Mee Kim, Jae-Ho Cheong, Jeeyun Lee, Sung Hoon Noh, Tae Sung Sohn, Yoon Young Choi, Ji Yeong An
      Annals of Surgical Oncology.2021; 28(13): 8908.     CrossRef
    • Increasing Mortality in Korean Patients With Breast Cancer: High Mortality Rate in Elderly Breast Cancer Population Due to Suboptimal Treatment and Other Diseases
      Hyangsuk Choi, Hany Noh, Kwang-Min Kim, In-Jeong Cho, Seungtaek Lim, Airi Han
      Cancer Control.2021;[Epub]     CrossRef
    • Association of Multifocality With Prognosis of Papillary Thyroid Carcinoma
      Hyeonkyeong Kim, Hyungju Kwon, Byung-In Moon
      JAMA Otolaryngology–Head & Neck Surgery.2021; 147(10): 847.     CrossRef
    • Characteristics of Patients Presenting to a Psycho-Oncology Outpatient Clinic
      C. Hyung Keun Park, Harin Kim, Yangsik Kim, Yeon Ho Joo
      Psychiatry Investigation.2021; 18(8): 743.     CrossRef
    • Insomnia, Anxiety, and Depression in Patients First Diagnosed With Female Cancer
      Dham Ho, Sun-Young Kim, Soo In Kim, Sung-Youn Kim, Weon-Jeong Lim
      Psychiatry Investigation.2021; 18(8): 755.     CrossRef
    • Cost-Effectiveness Analysis of Active Surveillance Compared to Early Surgery in Small Papillary Thyroid Cancer: A Systemic Review
      Han-sang Baek, Chai-ho Jeong, Jeonghoon Ha, Ja-Seong Bae, Jeong-soo Kim, Dong-Jun Lim, Chul-Min Kim
      Cancer Management and Research.2021; Volume 13: 6721.     CrossRef
    • Patient-Level Cancer Prediction Models From a Nationwide Patient Cohort: Model Development and Validation
      Eunsaem Lee, Se Young Jung, Hyung Ju Hwang, Jaewoo Jung
      JMIR Medical Informatics.2021; 9(8): e29807.     CrossRef
    • International comparison of trends in cancer mortality: Japan has fallen behind in screening-related cancers
      Kota Katanoda, Yuri Ito, Tomotaka Sobue
      Japanese Journal of Clinical Oncology.2021; 51(11): 1680.     CrossRef
    • Do Patients Residing in Provincial Areas Transport and Spend More on Cancer Treatment in Korea?
      Woorim Kim, Kyu-Tae Han, Seungju Kim
      International Journal of Environmental Research and Public Health.2021; 18(17): 9247.     CrossRef
    • Metabolic Effects of Gastrectomy and Duodenal Bypass in Early Gastric Cancer Patients with T2DM: A Prospective Single-Center Cohort Study
      Young Ki Lee, Eun Kyung Lee, You Jin Lee, Bang Wool Eom, Hong Man Yoon, Young-Il Kim, Soo Jeong Cho, Jong Yeul Lee, Chan Gyoo Kim, Sun-Young Kong, Min Kyong Yoo, Yul Hwangbo, Young-Woo Kim, Il Ju Choi, Hak Jin Kim, Mi Hyang Kwak, Keun Won Ryu
      Journal of Clinical Medicine.2021; 10(17): 4008.     CrossRef
    • Elevated Neutrophil-to-Lymphocyte Ratio in Perioperative Periods is Suggestive of Poor Prognosis in Patients with Colorectal Cancer
      Jung Hyun Kim, Jae-Hoon Lee, Hye Sun Lee, Su-Jin Shin, Eun Jung Park, Eun-Suk Cho, Seung Hyuk Baik, Kang Young Lee, Jeonghyun Kang
      Journal of Inflammation Research.2021; Volume 14: 4457.     CrossRef
    • Single Surgeon Experience with 500 Cases of the Robotic Bilateral Axillary Breast Approach (BABA) for Thyroid Surgery Using the Da-Vinci Xi System
      Yun-Suk Choi, Woo-Young Shin, Jin-Wook Yi
      Journal of Clinical Medicine.2021; 10(18): 4048.     CrossRef
    • Comparison of clinicopathological characteristics and prognosis in breast cancer patients with different Breast Imaging Reporting and Data System categories
      Bong Kyun Kim, Jai Min Ryu, Se Jeong Oh, Jaihong Han, Jung Eun Choi, Joon Jeong, Young Jin Suh, Jina Lee, Woo Young Sun
      Annals of Surgical Treatment and Research.2021; 101(3): 131.     CrossRef
    • Characterization of Circulating IL-7R Positive Cell Populations for Early Detection of Pancreatic Ductal Adenocarcinoma
      Sun-Hee Heo, Sung Ill Jang, So Young Kim, Bongkun Choi, Dong Ki Lee, Hyung Keun Lee, Eun-Ju Chang
      Journal of Clinical Medicine.2021; 10(18): 4157.     CrossRef
    • A nationwide study of patients with monoclonal gammopathy of undetermined significance with a 10-year follow-up in South Korea
      Ka-Won Kang, Ji Eun Song, Byung-Hyun Lee, Min Ji Jeon, Eun Sang Yu, Dae Sik Kim, Se Ryeon Lee, Hwa Jung Sung, Chul Won Choi, Yong Park, Byung Soo Kim
      Scientific Reports.2021;[Epub]     CrossRef
    • The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999-2017: Korea Central Cancer Registry
      Hyeong In Ha, Ha Kyun Chang, Soo Jin Park, Jiwon Lim, Young-Joo Won, Myong Cheol Lim
      Obstetrics & Gynecology Science.2021; 64(5): 444.     CrossRef
    • Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16)
      Hye Sook Han, Bum Jun Kim, Hee-Jung Jee, Min-Hee Ryu, Se Hoon Park, Sun Young Rha, Jong Gwang Kim, Woo Kyun Bae, Keun-Wook Lee, Do-Youn Oh, In-Ho Kim, Sun Jin Sym, So Yeon Oh, Hyeong Su Kim, Ji-Hye Byun, Dong Sook Kim, Young Ju Suh, Hyonggin An, Dae Young
      Therapeutic Advances in Medical Oncology.2021;[Epub]     CrossRef
    • Mobile Phone Use and Time Trend of Brain Cancer Incidence Rate in Korea
      Kyung‐Hwa Choi, Johyun Ha, Sanghyuk Bae, Ae‐Kyoung Lee, Hyung‐Do Choi, Young Hwan Ahn, Mina Ha, Hyunjoo Joo, Ho‐Jang Kwon, Kyu‐Won Jung
      Bioelectromagnetics.2021; 42(8): 629.     CrossRef
    • Trends in the Incidence and Survival Rates of Colorectal Signet-Ring Cell Carcinoma in the South Korean Population: Analysis of the Korea Central Cancer Registry Database
      Ji-Hoon Kim, Hyunil Kim, Jin Woo Kim, Hee Man Kim
      Journal of Clinical Medicine.2021; 10(18): 4258.     CrossRef
    • Clinical Outcomes of Endoscopic Submucosal Dissection for Early Gastric Cancer in Patients with Comorbidities
      Enerelt Natsagdorj, Sang Gyun Kim, Jinju Choi, Seungkyung Kang, Bokyung Kim, Eunwoo Lee, Hyunsoo Chung, Soo-Jeong Cho
      Journal of Gastric Cancer.2021;[Epub]     CrossRef
    • Incidence and treatment outcomes of ovarian sarcoma compared to epithelial ovarian cancer from the national cancer registry
      Hyeong In Ha, Sang-Hyun Cho, Jiwon Lim, Yeon Jee Lee, Chong Woo Yoo, Young-Joo Won, Myong Cheol Lim
      Gynecologic Oncology.2021; 163(3): 506.     CrossRef
    • Barriers and strategies for cervical cancer screening: What do female university students know and want?
      Hye Young Shin, Soo Yeon Song, Jae Kwan Jun, Ka Young Kim, Purum Kang, Nülüfer Erbil
      PLOS ONE.2021; 16(10): e0257529.     CrossRef
    • Analysis of the Occurrence of Diseases Following Gastrectomy for Early Gastric Cancer: a Nationwide Claims Study
      Ho Seok Seo, Yewon Na, Jaehun Jung
      Journal of Gastric Cancer.2021;[Epub]     CrossRef
    • Effects of Symptoms and Patient Activation on Sleep Disturbance in Patients with Acute Leukemia Undergoing Chemotherapy
      Suna Lee, Eunjung Ryu
      Asian Oncology Nursing.2021; 21(3): 173.     CrossRef
    • Pulmonary Metastasectomy in Colorectal Cancer: A Population-Based Retrospective Cohort Study Using the Korean National Health Insurance Database
      Woo Sik Yu, Mi Kyung Bae, Jung Kyu Choi, Young Ki Hong, In Kyu Park
      Cancer Research and Treatment.2021; 53(4): 1104.     CrossRef
    • Genomic Instability of Circulating Tumor DNA as a Prognostic Marker for Pancreatic Cancer Survival: A Prospective Cohort Study
      Sang Myung Woo, Min Kyeong Kim, Boram Park, Eun-Hae Cho, Tae-Rim Lee, Chang-Seok Ki, Kyong-Ah Yoon, Yun-Hee Kim, Wonyoung Choi, Do Yei Kim, Jin-Hyeok Hwang, Jae Hee Cho, Sung-Sik Han, Woo Jin Lee, Sang-Jae Park, Sun-Young Kong
      Cancers.2021; 13(21): 5466.     CrossRef
    • Epidemiologic trends in cancer-related emergency department utilization in Korea from 2015 to 2019
      Sun Young Lee, Young Sun Ro, Sang Do Shin, Sungwoo Moon
      Scientific Reports.2021;[Epub]     CrossRef
    • Screening Plasma Exosomal RNAs as Diagnostic Markers for Cervical Cancer: An Analysis of Patients Who Underwent Primary Chemoradiotherapy
      Oyeon Cho, Do-Wan Kim, Jae-Youn Cheong
      Biomolecules.2021; 11(11): 1691.     CrossRef
    • Spatial epidemiologic analysis of the liver cancer and gallbladder cancer incidence and its determinants in South Korea
      Jieun Jang, Dae-Sung Yoo, Byung Chul Chun
      BMC Public Health.2021;[Epub]     CrossRef
    • Temporal trend of gastric cancer burden along with its risk factors in China from 1990 to 2019, and projections until 2030: comparison with Japan, South Korea, and Mongolia
      Xiaorong Yang, Tongchao Zhang, Hong Zhang, Shaowei Sang, Hui Chen, Xiuli Zuo
      Biomarker Research.2021;[Epub]     CrossRef
    • Inhibition of the bromodomain and extra-terminal family of epigenetic regulators as a promising therapeutic approach for gastric cancer
      Sun Kyoung Kang, Hyun Joo Bae, Woo Sun Kwon, Tae Soo Kim, Kyoo Hyun Kim, Sejung Park, Seo Young Yu, Jihyun Hwang, Juin Park, Hyun Cheol Chung, Sun Young Rha
      Cellular Oncology.2021; 44(6): 1387.     CrossRef
    • Spatial distribution and determinants of thyroid cancer incidence from 1999 to 2013 in Korea
      Jieun Jang, Dae-Sung Yoo, Byung Chul Chun
      Scientific Reports.2021;[Epub]     CrossRef
    • Survival impact of additional chemotherapy after adjuvant concurrent chemoradiation in patients with early cervical cancer who underwent radical hysterectomy
      Se Ik Kim, Jeong Yun Kim, Chan Woo Wee, Maria Lee, Hee Seung Kim, Hyun Hoon Chung, Taek Sang Lee, Hye Won Jeon, Noh Hyun Park, Yong Sang Song, Tae Hun Kim
      BMC Cancer.2021;[Epub]     CrossRef
    • Disparities in stage at diagnosis for five common cancers in China: a multicentre, hospital-based, observational study
      Hongmei Zeng, Xianhui Ran, Lan An, Rongshou Zheng, Siwei Zhang, John S Ji, Yawei Zhang, Wanqing Chen, Wenqiang Wei, Jie He
      The Lancet Public Health.2021; 6(12): e877.     CrossRef
    • A prospective phase-II trial of biweekly docetaxel plus androgen deprivation therapy in patients with previously-untreated metastatic castration-naïve prostate cancer
      Seonggyu Byeon, Hongsik Kim, Hwang Gyun Jeon, Seong Il Seo, Seong Soo Jeon, Hyun Moo Lee, Soon Il Lee, Se Hoon Park
      BMC Cancer.2021;[Epub]     CrossRef
    • The Relationship Between Breast Density Change During Menopause and the Risk of Breast Cancer in Korean Women
      Danbee Kang, Ji-Yeon Kim, Ji-Young Kim, Han Song Mun, Sook Ja Yoon, Jieun Lee, Gayeon Han, Young-Hyuck Im, Soo-Young Shin, Se Kyung Lee, Jong-Han Yu, Kyung-Hyun Lee, Mincheol Kim, Dohyun Park, Yoon-Ho Choi, Ok Soon Jeong, Jean Hyoung Lee, Se Yong Jekal, J
      Cancer Prevention Research.2021; 14(12): 1119.     CrossRef
    • Esophageal Cancer in Korea: Epidemiology and Treatment Patterns
      Seong Yong Park, Dae Joon Kim
      Journal of Chest Surgery.2021; 54(6): 454.     CrossRef
    • Analysis of risk factors associated with survival in human epidermal growth factor receptor 2-positive ductal carcinoma in situ using Korean Breast Cancer Society Database
      Sol Ji Ahn, Chang Ik Yoon, Pill Sun Paik, Tae-Kyung Yoo, Namsun Park, Eun Sook Lee, Jung Eun Choi, Joon Jeong, Hyun Jo Youn, Woo-Chan Park
      Annals of Surgical Treatment and Research.2021; 101(6): 315.     CrossRef
    • Clinical Application of Automated Breast Ultrasound
      Sung Hun Kim
      Clinical Ultrasound.2021; 6(2): 35.     CrossRef
    • Effect of Helicobacter pylori Eradication on Epigenetic Changes in Gastric Cancer-related Genes
      Ji Min Choi, Sang Gyun Kim
      The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2021; 21(4): 256.     CrossRef
    • Phase II study of DHP107 (oral paclitaxel) in the first-line treatment of HER2-negative recurrent or metastatic breast cancer (OPTIMAL study)
      Sung-Bae Kim, Jae Hong Seo, Jin-Hee Ahn, Tae-Yong Kim, Seok Yun Kang, Joohyuk Sohn, Yaewon Yang, Kyong Hwa Park, Yong Wha Moon, Seungtaek Lim, Myoung Joo Kang, Koung Eun Yoon, Hyun Ju Cho, Keun Seok Lee
      Therapeutic Advances in Medical Oncology.2021;[Epub]     CrossRef
    • Personalized 5-Year Prostate Cancer Risk Prediction Model in Korea Based on Nationwide Representative Data
      Yohwan Yeo, Dong Wook Shin, Jungkwon Lee, Kyungdo Han, Sang Hyun Park, Keun Hye Jeon, Jungeun Shin, Aesun Shin, Jinsung Park
      Journal of Personalized Medicine.2021; 12(1): 2.     CrossRef
    • Dietary Intake of Soy Products, Vegetables, and Dairy Products and Gastric Cancer Survival according to Histological Subtype: A long-term Prospective Cohort Study
      Jung Hyun Kwak, Chan Hyuk Park, Chang Soo Eun, Dong Soo Han, Yong Sung Kim, Kyu Sang Song, Bo Youl Choi, Hyun Ja Kim
      Journal of Gastric Cancer.2021; 21(4): 403.     CrossRef
    • Early Clinical Outcomes of the Morbidly Obese Patients Who Underwent Laparoscopic Sleeve Gastrectomy by Gastric Cancer Surgeons: the Analysis of Fifty Consecutive Cases
      Chang Seok Ko, Jin Ho Jheong, Seong-A Jeong, Chung Sik Gong, In-Seob Lee, Beom Su Kim, Byung Sik Kim, Hye Soon Park, Se Hee Min, Moon-Won Yoo
      Journal of Metabolic and Bariatric Surgery.2021; 10(2): 66.     CrossRef
    • Atypical Hyperplasia at the Margin of Frozen Sections from Breast-Conserving Surgery
      Yong Min Na, Young Jae Ryu, Hyo Soon Lim, Ji Shin Lee, Jin Seong Cho, Jung Han Yoon, Min Ho Park
      Journal of Breast Disease.2021; 9(2): 71.     CrossRef
    • Evaluation of the Value of Multiplex MicroRNA Analysis as a Breast Cancer Screening in Korean Women under 50 Years of Age with a High Proportion of Dense Breasts
      Ji Young Jang, Eun Young Ko, Ji Soo Jung, Kyung Nam Kang, Yeon Soo Kim, Chul Woo Kim
      Journal of Cancer Prevention.2021; 26(4): 258.     CrossRef
    • Comparison of Post-Operative Nutritional Status according to the Extent of Gastrectomy and the Reconstruction Method in Patients with Gastric Cancer
      Kyung Hwan Kim, Jong Hyuk Yoon, Geum Jong Song, Myoung Won Son, Sung Yong Kim, Moo Jun Baek, Moon Soo Lee
      Annals of Clinical Nutrition and Metabolism.2021; 13(2): 34.     CrossRef
    • Clinical significance of additional gastrectomy after non-curative endoscopic submucosal dissection for early gastric cancer: a retrospective single-center study
      Uicheon Jeong, Ho Yoon Bang, Pyeong Su Kim
      Korean Journal of Clinical Oncology.2021; 17(2): 68.     CrossRef
    • The classification capability of the Asia Pacific Colorectal Screening score in Korea: an analysis of the Cancer Screenee Cohort
      Xuan Quy Luu, Kyeongmin Lee, Jeongseon Kim, Dae Kyung Sohn, Aesun Shin, Kui Son Choi
      Epidemiology and Health.2021; 43: e2021069.     CrossRef
    • Gene Expression Profiling Identifies Akt as a Target for Radiosensitization in Gastric Cancer Cells
      Kyung Hwan Kim, Han Sang Kim, Sang Cheol Kim, DooA Kim, Yong Bae Kim, Hyun Cheol Chung, Sun Young Rha
      Frontiers in Oncology.2020;[Epub]     CrossRef
    • Surveillance Endoscopy Guidelines for Postgastrectomy Patients Based on Risk of Developing Remnant Gastric Cancer
      Eui Soo Han, Ho Seok Seo, Ji Hyun Kim, Han Hong Lee
      Annals of Surgical Oncology.2020; 27(11): 4216.     CrossRef
    • Breast Cancer Risk Prediction in Korean Women: Review and Perspectives on Personalized Breast Cancer Screening
      Do Yeun Kim, Hannah Lui Park
      Journal of Breast Cancer.2020; 23(4): 331.     CrossRef
    • Bone metastasis and skeletal-related events in patients with solid cancer: A Korean nationwide health insurance database study
      Soojung Hong, Taemi Youk, Su Jin Lee, Kyoung Min Kim, Claire M. Vajdic, Jason Chia-Hsun Hsieh
      PLOS ONE.2020; 15(7): e0234927.     CrossRef
    • The Impact of BRAF Mutation on the Recurrence of Papillary Thyroid Carcinoma: A Meta-Analysis
      Xin Li, Hyungju Kwon
      Cancers.2020; 12(8): 2056.     CrossRef
    • Trends of Incidence and Survival Rrates of Mucosa-associated Lymphoid Tissue Lymphoma in the Korean Population: Analysis of the Korea Central Cancer Registry Database
      Seok-Hoo Jeong, Shin Young Hyun, Ja Sung Choi, Hee Man Kim
      Journal of Korean Medical Science.2020;[Epub]     CrossRef
    • Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13–01)
      Yun-Gyoo Lee, Eun Joo Kang, Bhumsuk Keam, Jin-Hyuk Choi, Jin-Soo Kim, Keon Uk Park, Kyoung Eun Lee, Jung Hye Kwon, Keun-Wook Lee, Min Kyoung Kim, Hee Kyung Ahn, Seong Hoon Shin, Hye Ryun Kim, Sung-Bae Kim, Hwan Jung Yun
      BMC Cancer.2020;[Epub]     CrossRef
    • Alterations in Gastric Microbial Communities Are Associated with Risk of Gastric Cancer in a Korean Population: A Case-Control Study
      Madhawa Gunathilake, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Jaekyung Yoon, Woo Jun Sul, Jihyun F. Kim, Jeongseon Kim
      Cancers.2020; 12(9): 2619.     CrossRef
    • Upregulation of G Protein-Coupled Estrogen Receptor by Chrysin-Nanoparticles Inhibits Tumor Proliferation and Metastasis in Triple Negative Breast Cancer Xenograft Model
      Kyoung Mee Kim, Joohee Jung
      Frontiers in Endocrinology.2020;[Epub]     CrossRef
    • Economic burden of alcohol-related cancers in the Republic of Korea
      Minji Han, Binh Thang Tran, Heeyoun Cho, Jin-Kyoung Oh
      Drug and Alcohol Dependence.2020; 217: 108295.     CrossRef
    • Association between Family Histories of Thyroid Cancer and Thyroid Cancer Incidence: A Cross-Sectional Study Using the Korean Genome and Epidemiology Study Data
      Soo-Hwan Byun, Chanyang Min, Hyo-Geun Choi, Seok-Jin Hong
      Genes.2020; 11(9): 1039.     CrossRef
    • Effect of Citric Acid Cycle Genetic Variants and Their Interactions with Obesity, Physical Activity and Energy Intake on the Risk of Colorectal Cancer: Results from a Nested Case-Control Study in the UK Biobank
      Sooyoung Cho, Nan Song, Ji-Yeob Choi, Aesun Shin
      Cancers.2020; 12(10): 2939.     CrossRef
    • CD73 Overexpression Promotes Progression and Recurrence of Papillary Thyroid Carcinoma
      Young Mun Jeong, Haejin Cho, Tae-Min Kim, Yourha Kim, Sora Jeon, Andrey Bychkov, Chan Kwon Jung
      Cancers.2020; 12(10): 3042.     CrossRef
    • Survival Effects of Cytoreductive Surgery for Refractory Patients after Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer
      Wonkyo Shin, Joseph J. Noh, Sang-Soo Seo, Sokbom Kang, Chel-Hun Choi, Sang-Yoon Park, Byoung-Gie Kim, Myong Cheol Lim
      Yonsei Medical Journal.2020; 61(11): 935.     CrossRef
    • Stigma, Adjustment, and Quality of Life of Middle-aged Male Patients with Lung Cancer
      Miyoung Yoo, Eunyoung E. Suh
      Korean Journal of Adult Nursing.2020; 32(5): 494.     CrossRef
    • Impact of Adjuvant Radiotherapy on Survival Outcomes in Intermediate-Risk, Early-Stage Cervical Cancer: Analyses Regarding Surgical Approach of Radical Hysterectomy
      Se Ik Kim, Tae Hun Kim, Maria Lee, Hee Seung Kim, Hyun Hoon Chung, Taek Sang Lee, Hye Won Jeon, Jae-Weon Kim, Noh Hyun Park, Yong Sang Song
      Journal of Clinical Medicine.2020; 9(11): 3545.     CrossRef
    • Efficacy and feasibility of proton beam radiotherapy using the simultaneous integrated boost technique for locally advanced pancreatic cancer
      Tae Hyun Kim, Woo Jin Lee, Sang Myung Woo, Eun Sang Oh, Sang Hee Youn, Hye Young Jang, Sung-Sik Han, Sang-Jae Park, Yang-Gun Suh, Sung Ho Moon, Sang Soo Kim, Dae Yong Kim
      Scientific Reports.2020;[Epub]     CrossRef
    • Short-term bone marrow suppression in differentiated thyroid cancer patients after radioactive iodine treatment
      Wook Yi, Bo Hyun Kim, Mijin Kim, So Ree Ryang, Min Hee Jang, Jeong Mi Kim, Eun Heui Kim, Yun Kyung Jeon, Sang Soo Kim, In Joo Kim
      Endocrine Journal.2020; 67(12): 1193.     CrossRef
    • Transcriptome analysis of iBET-151, a BET inhibitor alone and in combination with paclitaxel in gastric cancer cells
      Sun Kyoung Kang, Hyun Joo Bae, Woo Sun Kwon, Jingmin Che, Tae Soo Kim, Hyun Cheol Chung, Sun Young Rha
      Genomics & Informatics.2020; 18(4): e37.     CrossRef
    • Regional Lymph Node Dissection as an Additional Treatment Option to Endoscopic Resection for Expanded Indications in Gastric Cancer: a Prospective Cohort Study
      Ho Seok Seo, Han Mo Yoo, Yoon Ju Jung, Sung Hak Lee, Jae Myung Park, Kyo Young Song, Eun Sun Jung, Myung-Gyu Choi, Cho Hyun Park
      Journal of Gastric Cancer.2020; 20(4): 442.     CrossRef
    • Clinicopathologic Analysis of Cathepsin B as a Prognostic Marker of Thyroid Cancer
      Eun-Kyung Kim, Min-Jeong Song, Ho Hee Jang, Yoo Seung Chung
      International Journal of Molecular Sciences.2020; 21(24): 9537.     CrossRef
    • Impact of Radiotherapy on Kidney Function among Patients Who Received Adjuvant Treatment for Gastric Cancer: Logistic and Linear Regression Analyses
      Jun Su Park, Jeong Il Yu, Do Hoon Lim, Heerim Nam, Young Il Kim, Jeeyun Lee, Won Ki Kang, Se Hoon Park, Seung Tae Kim, Jung Yong Hong, Tae Sung Sohn, Jun Ho Lee, Ji Yeong An, Min Gew Choi, Jae Moon Bae
      Cancers.2020; 13(1): 59.     CrossRef
    • Two-Stage Classification Method for MSI Status Prediction Based on Deep Learning Approach
      Hyunseok Lee, Jihyun Seo, Giwan Lee, Jongoh Park, Doyeob Yeo, Ayoung Hong
      Applied Sciences.2020; 11(1): 254.     CrossRef
    • Trends in Participation Rates of the National Cancer Screening Program among Cancer Survivors in Korea
      E Hwa Yun, Seri Hong, Eun Young Her, Bomi Park, Mina Suh, Kui Son Choi, Jae Kwan Jun
      Cancers.2020; 13(1): 81.     CrossRef
    • Current Quality Control Practices of Primary Care Clinics Participating in the National Cancer Screening Program in Korea
      Hyewon Lee, Bomi Park, Kyu-Tae Han, Eun Young Her, Jae Kwan Jun, Kui Son Choi, Mina Suh
      Quality Improvement in Health Care.2020; 26(2): 86.     CrossRef
    • Is the Internal Jugular Node Dissection without Level V Sufficient in Patients with Papillary Thyroid Carcinoma with Lateral Neck Node Metastasis?
      Cho Rok Lee, Jin Kyong Kim, Sang-Wook Kang, Jandee Lee, Jong Ju Jeong, Kee-Hyun Nam, Woong Youn Chung
      Journal of Endocrine Surgery.2020; 20(3): 31.     CrossRef

    • PubReader PubReader
    • ePub LinkePub Link
    • Cite
      CITE
      export Copy Download
      Close
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.
      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017
      Cancer Res Treat. 2020;52(2):335-350.   Published online March 16, 2020
      DOI: https://doi.org/10.4143/crt.2020.206
      Close
    • XML DownloadXML Download
    • 0
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017
    Image Image Image Image Image Image Image
    Fig. 1. The five common sites of cancer incidence by age group and sex for 2017 in Korea. (A) Men. (B) Women. Numbers on each section are age-specific incidence rates per 100,000. CNS, central nervous system. a)Includes the gallbladder and other/unspecified parts of the biliary tract.
    Fig. 2. Age-specific incidence rates of common cancers for 2017 in Korea. (A) Men. (B) Women.
    Fig. 3. Annual age-standardized cancer incidence and mortality rates by sex for all sites from 1983 to 2017 in Korea. Age standardization was based on Segi’s world standard population.
    Fig. 4. Trends in age-standardized incidences of selected cancers by sex from 1999 to 2017 in Korea. (A) Men. (B) Women. Age standardization was based on Segi’s world standard population.
    Fig. 5. Trends in age-standardized mortalities of selected cancers by sex from 1983 to 2017 in Korea. (A) Men. (B) Women. Age standardization was based on Segi’s world standard population. a)Cancers of cervix uteri, corpus uteri, and unspecified parts of the uterus were combined (C53-C55), due to their unclear classifications in the past.
    Fig. 6. Five-year relative survival rates by stage at diagnosis and stage distribution of selected cancers by sex in Korea, 2013-2017. (A) Men. (B) Women. Staging according to the Surveillance, Epidemiology, and End Results (SEER) stage categories. For each cancer type, stage categories do not total 100% because sufficient information was not available to stage all cases. a)Includes the gallbladder and other/unspecified parts of the biliary tract.
    Fig. 7. Prevalent cases of common cancers by time since cancer diagnosis. Prevalent cases were defined as the number of cancer patients alive on January 1, 2018 among all cancer patients diagnosed between 1999 and 2017.

    Fig. 1.

    Fig. 2.

    Fig. 3.

    Fig. 4.

    Fig. 5.

    Fig. 6.

    Fig. 7.

    Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017
    Site/Type New cases
    		 Deaths
    		 Prevalent casesa)
    Both sexes Men Women Both sexes Men Women Both sexes Men Women
    All sites 232,255 122,292 109,963 78,863 48,866 29,997 1,867,405 819,838 1,047,567
    Lip, oral cavity, and pharynx 3,667 2,625 1,042 1,199 928 271 25,450 17,007 8,443
    Esophagus 2,483 2,239 244 1,423 1,290 133 10,403 9,319 1,084
    Stomach 29,685 19,916 9,769 8,034 5,166 2,868 289,223 191,389 97,834
    Colon and rectum 28,111 16,653 11,458 8,691 4,981 3,710 251,063 149,310 101,753
    Liverb) 15,405 11,500 3,905 10,721 7,982 2,739 68,077 51,068 17,009
    Gallbladderc) 6,846 3,555 3,291 4,717 2,392 2,325 22,375 11,479 10,896
    Pancreas 7,032 3,733 3,299 5,782 2,976 2,806 11,776 6,172 5,604
    Larynx 1,218 1,142 76 372 349 23 10,990 10,334 656
    Lungd) 26,985 18,657 8,328 17,980 13,272 4,708 84,242 51,808 32,434
    Breast 22,395 95 22,300 2,517 20 2,497 217,203 801 216,402
    Cervix uteri 3,469 - 3,469 868 - 868 54,914 - 54,914
    Corpus uteri 2,986 - 2,986 320 - 320 25,590 - 25,590
    Ovary 2,702 - 2,702 1,149 - 1,149 21,013 - 21,013
    Prostate 12,797 12,797 - 1,821 1,821 - 86,435 86,435 -
    Testis 262 262 - 15 15 - 3,441 3,441 -
    Kidney 5,299 3,617 1,682 1,000 687 313 42,513 28,611 13,902
    Bladder 4,379 3,525 854 1,438 1,100 338 35,585 29,024 6,561
    Brain and CNS 1,947 1,036 911 1,319 738 581 11,719 5,998 5,721
    Thyroid 26,170 6,035 20,135 369 111 258 405,032 71,015 334,017
    Hodgkin lymphoma 287 172 115 55 43 12 3,004 1,871 1,133
    Non-Hodgkin lymphoma 4,762 2,708 2,054 1,786 997 789 32,519 18,475 14,044
    Multiple myeloma 1,629 857 772 964 512 452 6,375 3,339 3,036
    Leukemia 3,366 1,916 1,450 1,834 1,042 792 22,218 12,369 9,849
    Other and ill-defined 18,373 9,252 9,121 4,489 2,444 2,045 126,245 60,573 65,672
    Site/Type Crude incidence rate per 100,000
    		 Age-standardized incidence rate per 100,000a)
    Both sexes Men Women Both sexes Men Women
    All sites 453.4 478.1 428.6 264.4 291.3 251.5
    Lip, oral cavity, and pharynx 7.2 10.3 4.1 4.3 6.3 2.4
    Esophagus 4.8 8.8 1.0 2.6 5.1 0.5
    Stomach 57.9 77.9 38.1 32.0 46.4 19.6
    Colon and rectum 54.9 65.1 44.7 29.7 38.8 21.8
    Liverb) 30.1 45.0 15.2 16.5 26.8 7.2
    Gallbladderc) 13.4 13.9 12.8 6.6 8.0 5.5
    Pancreas 13.7 14.6 12.9 7.1 8.5 5.8
    Larynx 2.4 4.5 0.3 1.3 2.6 0.1
    Lungd) 52.7 72.9 32.5 27.1 42.1 15.5
    Breast 43.7 0.4 86.9 28.0 0.2 55.6
    Cervix uteri 6.8 - 13.5 4.4 - 8.7
    Corpus uteri 5.8 - 11.6 3.7 - 7.3
    Ovary 5.3 - 10.5 3.4 - 6.8
    Prostate 25.0 50.0 - 12.9 28.9 -
    Testis 0.5 1.0 - 0.5 1.0 -
    Kidney 10.3 14.1 6.6 6.3 8.9 3.8
    Bladder 8.5 13.8 3.3 4.3 8.0 1.5
    Brain and CNS 3.8 4.1 3.6 2.9 3.1 2.7
    Thyroid 51.1 23.6 78.5 36.8 17.0 57.2
    Hodgkin lymphoma 0.6 0.7 0.4 0.5 0.6 0.4
    Non-Hodgkin lymphoma 9.3 10.6 8.0 6.0 7.4 4.8
    Multiple myeloma 3.2 3.4 3.0 1.7 2.0 1.5
    Leukemia 6.6 7.5 5.7 5.2 6.2 4.3
    Other and ill-defined 35.9 36.2 35.6 20.6 23.2 18.5
    Rank Cause of death No. of deaths Percentage of all deaths Age-standardized mortality rate per 100,000a)
    All causes 285,534 100.0 270.1
    1 Cancer 78,863 27.6 76.6
    2 Heart disease 30,852 10.8 27.2
    3 Cerebrovascular disease 22,745 8.0 19.7
    4 Pneumonia 19,378 6.8 15.6
    5 Intentional self-harm (suicide) 12,463 4.4 16.7
    6 Diabetes mellitus 9,184 3.2 8.0
    7 Disease of liver 6,797 2.4 7.5
    8 Chronic lower respiratory diseases 6,750 2.4 5.4
    9 Hypertensive diseases 5,775 2.0 4.6
    10 Transport accidents 5,028 1.8 6.4
    Others 87,699 30.7 82.5
    Site/Type Crude incidence rate per 100,000
    		 Age-standardized incidence rate per 100,000a)
    Both sexes Men Women Both sexes Men Women
    All sites 153.9 191.1 116.9 76.6 111.0 51.2
    Lip, oral cavity, and pharynx 2.3 3.6 1.1 1.2 2.1 0.5
    Esophagus 2.8 5.0 0.5 1.4 2.9 0.2
    Stomach 15.7 20.2 11.2 7.7 11.8 4.6
    Colon and rectum 17.0 19.5 14.5 8.1 11.3 5.6
    Liverb) 20.9 31.2 10.7 10.9 18.3 4.5
    Gallbladderc) 9.2 9.4 9.1 4.3 5.3 3.5
    Pancreas 11.3 11.6 10.9 5.6 6.7 4.6
    Larynx 0.7 1.4 0.1 0.3 0.8 0.0
    Lungd) 35.1 51.9 18.4 16.7 29.4 7.4
    Breast 4.9 0.1 9.7 2.9 0.0 5.5
    Cervix uteri 1.7 - 3.4 0.9 - 1.7
    Corpus uteri 0.6 - 1.2 0.3 - 0.7
    Ovary 2.2 - 4.5 1.2 - 2.4
    Prostate 3.6 7.1 - 1.5 4.0 -
    Testis 0.0 0.1 - 0.0 0.0 -
    Kidney 2.0 2.7 1.2 1.0 1.6 0.5
    Bladder 2.8 4.3 1.3 1.2 2.5 0.5
    Brain and CNS 2.6 2.9 2.3 1.7 2.0 1.4
    Thyroid 0.7 0.4 1.0 0.3 0.2 0.4
    Hodgkin lymphoma 0.1 0.2 0.0 0.1 0.1 0.0
    Non-Hodgkin lymphoma 3.5 3.9 3.1 1.8 2.3 1.4
    Multiple myeloma 1.9 2.0 1.8 0.9 1.1 0.8
    Leukemia 3.6 4.1 3.1 2.1 2.7 1.7
    Other and ill-defined 8.8 9.6 8.0 4.5 5.8 3.5
    Site/Type Both sexes
    		 Men
    		 Women
    1999 2017 Trend 1
    		 Trend 2
    		 1999 2017 Trend 1
    		 Trend 2
    		 1999 2017 Trend 1
    		 Trend 2
    Year APC Year APC Year APC Year APC Year APC Year APC
    All sites 211.6 264.4 1999-2011 3.5a) 2011-2017 –2.7a) 285.4 291.3 1999-2011 1.6a) 2011-2017 –2.7a) 162.7 251.5 1999-2011 5.6a) 2011-2017 –2.9a)
    Lip, oral cavity, and pharynx 3.6 4.3 1999-2017 0.6a) - - 6.1 6.3 1999-2017 –0.1 - - 1.6 2.4 1999-2017 1.5a) - -
    Esophagus 4.0 2.6 1999-2017 –2.3a) - - 8.8 5.1 1999-2017 –2.8a) - - 0.6 0.5 1999-2017 –1.3a) - -
    Stomach 43.6 32.0 1999-2011 –0.2 2011-2017 –4.7a) 66.1 46.4 1999-2011 –0.4a) 2011-2017 –5.2a) 26.7 19.6 1999-2011 –0.4 2011-2017 –4.2a)
    Colon and rectum 20.5 29.7 1999-2010 5.9a) 2010-2017 –4.2a) 26.2 38.8 1999-2010 6.4a) 2010-2017 –4.7a) 16.5 21.8 1999-2010 4.7a) 2010-2017 –3.7a)
    Liverb) 27.8 16.5 1999-2010 –1.7a) 2010-2017 –4.5a) 46.6 26.8 1999-2009 –1.8a) 2009-2017 –4.2a) 12.2 7.2 1999-2010 –1.4a) 2010-2017 –4.9a)
    Gallbladderc) 6.5 6.6 1999-2004 1.4 2004-2017 –0.3 8.1 8.0 1999-2017 0.0 - - 5.4 5.5 1999-2002 3.3 2002-2017 –0.5a)
    Pancreas 5.6 7.1 1999-2017 1.4a) - - 7.8 8.5 1999-2017 0.6a) - - 4.0 5.8 1999-2017 2.3a) - -
    Larynx 2.4 1.3 1999-2017 –3.6a) - - 5.0 2.6 1999-2017 –3.8a) - - 0.4 0.1 1999-2007 –9.2a) 2007-2017 –3.5a)
    Lungd) 28.4 27.1 1999-2010 0.2 2010-2017 –0.9a) 51.3 42.1 1999-2005 0.0 2005-2017 –1.5a) 12.5 15.5 1999-2011 1.9a) 2011-2017 0.2
    Breast 11.0 28.0 1999-2002 10.2a) 2002-2017 4.7a) 0.2 0.2 1999-2017 –0.5 - - 21.4 55.6 1999-2007 6.6a) 2007-2017 4.4a)
    Cervix uteri 8.6 4.4 1999-2007 –4.7a) 2007-2017 –3.1a) - - - - - - 16.4 8.7 1999-2007 –4.6a) 2007-2017 –2.8a)
    Corpus uteri 1.4 3.7 1999-2017 5.1a) - - - - - - - - 2.8 7.3 1999-2017 5.3a) - -
    Ovary 2.7 3.4 1999-2017 1.6a) - - - - - - - - 5.1 6.8 1999-2017 1.9a) - -
    Prostate 3.1 12.9 1999-2009 14.6a) 2009-2017 1.5a) 8.4 28.9 1999-2009 13.1a) 2009-2017 0.8 - - - - - -
    Testis 0.3 0.5 1999-2015 4.9a) 2015-2017 –2.2 0.5 1.0 1999-2015 4.8a) 2015-2017 –2.4 - - - - - -
    Kidney 3.0 6.3 1999-2009 6.5a) 2009-2017 1.9a) 4.6 8.9 1999-2010 5.9a) 2010-2017 1.1a) 1.7 3.8 1999-2008 6.6a) 2008-2017 2.4a)
    Bladder 4.6 4.3 1999-2004 2.0a) 2004-2017 –1.2a) 9.0 8.0 1999-2004 1.9a) 2004-2017 –1.5a) 1.6 1.5 1999-2017 –1.0a) - -
    Brain and CNS 2.8 2.9 1999-2017 0.2 - - 3.2 3.1 1999-2017 0.2 - - 2.6 2.7 1999-2017 0.2 - -
    Thyroid 6.5 36.8 1999-2011 22.2a) 2011-2017 –11.2a) 2.1 17.0 1999-2011 24.8a) 2011-2017 –6.7a) 10.7 57.2 1999-2011 21.9a) 2011-2017 –12.2a)
    Hodgkin lymphoma 0.3 0.5 1999-2017 3.9a) - - 0.4 0.6 1999-2017 3.0a) - - 0.1 0.4 1999-2017 5.1a) - -
    Non-Hodgkin lymphoma 4.3 6.0 1999-2017 2.3a) - - 5.6 7.4 1999-2017 1.9a) - - 3.3 4.8 1999-2017 2.6a) - -
    Multiple myeloma 1.0 1.7 1999-2012 3.7a) 2012-2017 1.0 1.2 2.0 1999-2012 3.5a) 2012-2017 0.4 0.8 1.5 1999-2006 5.9a) 2006-2017 2.3a)
    Leukemia 4.7 5.2 1999-2017 0.9a) - - 5.5 6.2 1999-2017 1.0a) - - 3.9 4.3 1999-2017 0.7a) - -
    Other and ill-defined 14.9 20.6 1999-2010 2.8a) 2010-2017 1.4a) 18.6 23.2 1999-2017 1.7a) - - 12.3 18.5 1999-2010 3.4a) 2010-2017 1.3a)
    Site/Type Both sexes
    		 Men
    		 Women
    1999 2017 Trend 1
    		 Trend 2
    		 1999 2017 Trend 1
    		 Trend 2
    		 1999 2017 Trend 1
    		 Trend 2
    Year APC Year APC Year APC Year APC Year APC Year APC
    All sites 114.3 76.6 1999-2002 1.2 2002-2017 –2.8a) 176.6 111.0 1999-2002 1.4 2002-2017 –3.2a) 70.6 51.2 1999-2002 1.1 2002-2017 –2.3a)
    Lip, oral cavity, and pharynx 1.1 1.2 1999-2017 –1.7a) - - 2.0 2.1 1999-2017 –2.0a) - - 0.4 0.5 1999-2017 –2.5a) - -
    Esophagus 3.1 1.4 1999-2017 –4.4a) - - 6.8 2.9 1999-2017 –4.7a) - - 0.5 0.2 1999-2010 –6.3a) 2010-2017 –1.3
    Stomach 23.8 7.7 1999-2003 –3.1a) 2003-2017 –6.8a) 36.9 11.8 1999-2003 –2.4a) 2003-2017 –7.1a) 14.6 4.6 1999-2003 –4.4a) 2003-2017 –6.6a)
    Colon and rectum 7.7 8.1 1999-2005 4.6a) 2005-2017 –1.9a) 10.5 11.3 1999-2007 3.3a) 2007-2017 –2.3a) 6.0 5.6 1999-2005 3.9a) 2005-2017 –2.4a)
    Liverb) 20.4 10.9 1999-2003 –0.1 2003-2017 –4.0a) 35.3 18.3 1999-2008 –2.6a) 2008-2017 –4.6a) 8.3 4.5 1999-2002 3.4 2002-2017 –4.0a)
    Gallbladderc) 5.2 4.3 1999-2001 6.3 2001-2017 –2.4a) 6.8 5.3 1999-2017 –2.2a) - - 4.1 3.5 1999-2001 8.4 2001-2017 –2.4a)
    Pancreas 5.4 5.6 1999-2017 0.2a) - - 7.6 6.7 1999-2015 –0.3a) 2015-2017 –3.6 3.9 4.6 1999-2017 0.9a) - -
    Larynx 1.6 0.3 1999-2017 –9.3a) - - 3.4 0.8 1999-2017 –8.9a) - - 0.4 0.0 1999-2010 –15.2a) 2010-2017 –8.5a)
    Lungd) 22.4 16.7 1999-2001 2.1 2001-2017 –2.2a) 41.5 29.4 1999-2002 2.0 2002-2017 –2.6a) 9.4 7.4 1999-2013 –1.0a) 2013-2017 –4.5a)
    Breast 2.2 2.9 1999-2003 3.3a) 2003-2017 1.1a) 0.1 0.0 1999-2017 –4.1a) - - 4.2 5.5 1999-2004 3.1a) 2004-2017 1.3a)
    Cervix uteri 1.4 0.9 1999-2003 8.3a) 2003-2017 –5.1a) - - - - - - 2.6 1.7 1999-2003 7.7a) 2003-2017 –4.8a)
    Corpus uteri 0.1 0.3 1999-2002 52.8a) 2002-2017 3.1a) - - - - - - 0.1 0.7 1999-2003 35.3a) 2003-2017 3.1a)
    Ovary 0.9 1.2 1999-2001 10.3 2001-2017 0.3 - - - - - - 1.7 2.4 1999-2001 9.6 2001-2017 0.7a)
    Prostate 0.9 1.5 1999-2004 10.0a) 2004-2017 –0.1 2.6 4.0 1999-2004 10.0a) 2004-2017 –0.7 - - - - - -
    Testis 0.0 0.0 1999-2017 –2.6a) - - 0.1 0.0 1999-2017 –3.0a) - - - - - - - -
    Kidney 1.1 1.0 1999-2017 –0.2 - - 1.8 1.6 1999-2017 –0.2 - - 0.5 0.5 1999-2017 –0.6 - -
    Bladder 1.3 1.2 1999-2001 9.9 2001-2017 –1.7a) 2.6 2.5 1999-2017 –1.6a) - - 0.5 0.5 1999-2001 10.5 2001-2017 –1.8a)
    Brain and CNS 1.9 1.7 1999-2002 4.1 2002-2017 –1.9a) 2.2 2.0 1999-2017 –1.5a) - - 1.6 1.4 1999-2017 –1.4a) - -
    Thyroid 0.4 0.3 1999-2003 7.5a) 2003-2017 –4.5a) 0.3 0.2 1999-2003 10.2 2003-2017 –4.5a) 0.5 0.4 1999-2004 4.5 2004-2017 –4.9a)
    Hodgkin lymphoma 0.0 0.1 1999-2004 22.8a) 2004-2017 –1.6 0.0 0.1 1999-2004 18.8a) 2004-2017 –1.8 0.0 0.0 1999-2014 5.7a) 2014-2017 –32.2
    Non-Hodgkin lymphoma 2.1 1.8 1999-2017 –1.0a) - - 3.0 2.3 1999-2017 –1.3a) - - 1.4 1.4 1999-2017 –0.5 - -
    Multiple myeloma 0.6 0.9 1999-2003 13.1a) 2003-2017 0.7 0.8 1.1 1999-2003 11.5a) 2003-2017 0.5 0.4 0.8 1999-2005 10.0a) 2005-2017 0.2
    Leukemia 2.9 2.1 1999-2017 –1.8a) - - 3.5 2.7 1999-2017 –1.7a) - - 2.4 1.7 1999-2017 –1.9a) - -
    Other and ill-defined 7.8 4.5 1999-2017 –2.9a) - - 9.0 5.8 1999-2017 –2.7a) - - 7.0 3.5 1999-2005 –7.1a) 2005-2017 –2.0a)
    Site/Type Both sexes
    		 Men
    		 Women
    1993-1995 1996-2000 2001-2005 2006-2010 2011-2015 2013-2017 Changea) 1993-1995 1996-2000 2001-2005 2006-2010 2011-2015 2013-2017 Changea) 1993-1995 1996-2000 2001-2005 2006-2010 2011-2015 2013-2017 Changea)
    All sites 42.9 45.1 54.1 65.5 70.7 70.4 27.5 33.2 36.3 45.6 56.8 63.1 63.5 30.3 55.1 56.4 64.3 74.4 78.4 77.5 22.4
    All sites excluding thyroid 41.2 43.3 50.8 59.0 64.2 65.0 23.8 32.7 35.8 44.7 54.6 60.3 61.0 28.3 52.6 53.5 59.1 65.0 69.3 70.1 17.5
    Lip, oral cavity, and pharynx 42.1 47.4 54.5 61.0 65.3 66.7 24.6 36.6 41.7 49.6 56.9 61.7 63.7 27.1 59.3 64.5 68.1 72.0 74.4 74.1 14.8
    Esophagus 14.0 15.7 21.5 29.9 36.4 38.0 24.0 13.1 14.8 20.7 29.3 36.1 37.5 24.4 25.0 25.9 29.8 37.1 39.7 42.2 17.2
    Stomach 43.9 47.3 58.0 68.4 75.9 76.5 32.6 43.9 47.6 58.7 69.1 76.8 77.5 33.6 43.7 46.8 56.6 67.0 74.0 74.6 30.9
    Colon and rectum 56.2 58.8 66.9 73.9 76.2 75.0 18.8 56.6 59.8 68.8 75.8 77.9 76.6 20.0 55.7 57.7 64.4 71.1 73.7 72.6 16.9
    Liverb) 11.7 14.1 20.5 28.2 34.3 35.6 23.9 10.8 13.8 20.4 28.2 34.8 36.4 25.6 15.0 15.1 20.9 28.3 32.7 33.2 18.2
    Gallbladderc) 18.7 20.7 23.1 26.9 28.8 28.9 10.2 18.0 21.1 23.5 27.8 29.5 29.7 11.7 19.3 20.3 22.7 26.0 28.1 28.0 8.7
    Pancreas 10.6 8.7 8.4 8.5 10.8 12.2 1.6 10.0 8.3 8.4 8.3 10.2 11.8 1.8 11.5 9.2 8.4 8.8 11.4 12.5 1.0
    Larynx 61.6 63.3 66.5 73.2 75.0 77.0 15.4 62.1 63.7 67.1 73.5 75.4 77.4 15.3 56.3 58.9 58.6 68.0 69.2 69.6 13.3
    Lungd) 12.5 13.6 16.5 20.2 27.5 30.2 17.7 11.6 12.4 15.3 18.0 23.2 25.2 13.6 15.8 17.5 20.1 26.0 37.2 41.5 25.7
    Breast 79.2 83.6 88.6 91.2 92.7 93.2 14.0 77.1 84.3 87.5 89.9 89.4 94.7 17.6 79.2 83.6 88.7 91.2 92.7 93.2 14.0
    Cervix uteri 78.3 80.3 81.5 80.7 80.2 80.2 1.9 - - - - - - - 78.3 80.3 81.5 80.7 80.2 80.2 1.9
    Corpus uteri 82.9 82.0 84.8 86.5 87.8 88.2 5.3 - - - - - - - 82.9 82.0 84.8 86.5 87.8 88.2 5.3
    Ovary 60.1 59.4 61.7 61.2 64.3 64.9 4.8 - - - - - - - 60.1 59.4 61.7 61.2 64.3 64.9 4.8
    Prostate 59.1 69.2 81.0 91.9 94.1 94.1 35.0 59.1 69.2 81.0 91.9 94.1 94.1 35.0 - - - - - - -
    Testis 87.4 90.4 90.7 93.1 95.1 95.2 7.8 87.4 90.4 90.7 93.1 95.1 95.2 7.8 - - - - - - -
    Kidney 64.3 67.0 73.6 78.6 82.4 83.1 18.8 63.5 65.3 73.0 78.4 82.1 83.1 19.6 65.9 70.3 74.9 78.9 83.2 82.9 17.0
    Bladder 70.7 73.6 76.0 77.2 76.4 76.8 6.1 71.6 75.1 77.8 79.2 78.3 78.8 7.2 67.1 67.3 69.1 69.1 68.6 68.9 1.8
    Brain and CNS 40.4 39.9 41.0 42.9 41.3 40.8 0.4 39.1 38.7 40.3 41.3 39.7 39.2 0.1 42.1 41.4 41.8 44.6 43.0 42.5 0.4
    Thyroid 94.5 95.0 98.4 100.0 100.2 100.1 5.6 87.9 89.6 96.0 100.2 100.6 100.4 12.5 95.7 96.0 98.7 99.9 100.1 100.0 4.3
    Hodgkin lymphoma 70.1 71.9 76.7 81.0 82.2 83.7 13.6 69.2 69.3 74.7 80.8 81.7 81.3 12.1 71.5 77.3 80.7 81.5 83.1 87.8 16.3
    Non-Hodgkin lymphoma 48.3 51.1 56.0 59.4 62.8 63.2 14.9 46.9 49.6 55.0 59.2 62.7 63.9 17.0 50.6 53.3 57.5 59.7 62.9 62.2 11.6
    Multiple myeloma 23.5 21.0 29.7 35.0 41.2 43.3 19.8 23.0 19.1 29.8 35.2 40.8 43.6 20.6 24.1 23.3 29.5 34.7 41.7 43.1 19.0
    Leukemia 27.5 34.3 42.0 47.7 51.9 53.0 25.5 27.3 33.3 41.8 46.9 52.2 53.6 26.3 27.8 35.5 42.2 48.7 51.5 52.3 24.5
    Other and ill-defined 44.5 48.3 57.8 67.6 72.6 74.0 29.5 39.6 44.7 54.0 63.8 69.3 70.9 31.3 50.1 52.6 61.9 71.5 76.0 77.0 26.9
    Site/Type Crude prevalence rate per 100,000a)
    		 Age-standardized prevalence rate per 100,000b)
    Both sexes Men Women Both sexes Men Women
    All sites 3,645.1 3,205.4 4,083.5 2,126.0 1,952.5 2,384.7
    Lip, oral cavity, and pharynx 49.7 66.5 32.9 29.5 41.2 19.2
    Esophagus 20.3 36.4 4.2 10.7 21.1 2.0
    Stomach 564.6 748.3 381.4 301.5 437.6 188.9
    Colon and rectum 490.1 583.8 396.6 258.8 343.0 190.6
    Liverc) 132.9 199.7 66.3 75.5 120.3 34.8
    Gallbladderd) 43.7 44.9 42.5 22.1 25.9 19.1
    Pancreas 23.0 24.1 21.8 12.8 14.5 11.4
    Larynx 21.5 40.4 2.6 11.2 23.4 1.2
    Lunge) 164.4 202.6 126.4 87.0 118.0 63.2
    Breast 424.0 3.1 843.5 255.9 1.9 503.7
    Cervix uteri 107.2 - 214.1 63.6 - 124.3
    Corpus uteri 50.0 - 99.8 30.2 - 59.4
    Ovary 41.0 - 81.9 26.9 - 53.5
    Prostate 168.7 337.9 - 80.2 189.3 -
    Testis 6.7 13.5 - 6.0 11.8 -
    Kidney 83.0 111.9 54.2 49.1 69.6 30.7
    Bladder 69.5 113.5 25.6 34.8 65.7 11.1
    Brain and CNS 22.9 23.5 22.3 19.1 20.1 18.0
    Thyroid 790.6 277.7 1,302.0 510.0 183.0 834.8
    Hodgkin lymphoma 5.9 7.3 4.4 4.8 5.8 3.8
    Non-Hodgkin lymphoma 63.5 72.2 54.7 43.1 51.7 35.0
    Multiple myeloma 12.4 13.1 11.8 6.8 7.7 6.0
    Leukemia 43.4 48.4 38.4 39.4 44.1 34.6
    Other and ill-defined 246.4 236.8 256.0 147.2 156.9 139.4
    Table 1. Cancer incidence, deaths, and prevalence by sex in Korea, 2017

    CNS, central nervous system.

    Limited-duration prevalent cases on January 1, 2017. These are patients who were diagnosed between January 1, 1999 and December 31, 2017, and who were alive on January 1, 2018. Multiple primary cancer cases were counted multiple times,

    Includes the liver and intrahepatic bile duct,

    Includes the gallbladder and other/unspecified parts of the biliary tract,

    Includes the lung and bronchus.

    Table 2. Crude and age-standardized cancer incidence rates by sex in Korea, 2017

    CNS, central nervous system.

    Age-adjusted using Segi’s world standard population,

    Includes the liver and intrahepatic bile duct,

    Includes the gallbladder and other/unspecified parts of the biliary tract,

    Includes the lung and bronchus.

    Table 3. The top 10 leading causes of death in Korea, 2017

    Source: Mortality Data, 2017, Statistics Korea [6].

    Age-adjusted using Segi’s world standard population.

    Table 4. Crude and age-standardized cancer mortality rates by sex in Korea, 2017

    CNS, central nervous system.

    Age-adjusted using Segi’s world standard population,

    Includes the liver and intrahepatic bile duct,

    Includes the gallbladder and other/unspecified parts of the biliary tract,

    Includes the lung and bronchus.

    Table 5. Trends in cancer incidence rates from 1999 to 2017 in Korea

    APC was calculated using age-standardized incidence data based on Segi’s world standard population. APC, annual percentage change; CNS, central nervous system.

    Significantly different from zero (p < 0.05),

    Includes the liver and intrahepatic bile duct,

    Includes the gallbladder and other/unspecified parts of the biliary tract,

    Includes the lung and bronchus.

    Table 6. Trends in cancer mortality rates from 1999 to 2017 in Korea

    APC was calculated using age-standardized incidence data based on Segi’s world standard population. APC, annual percentage change; CNS, central nervous system.

    Significantly different from zero (p < 0.05),

    Includes the liver and intrahepatic bile duct,

    Includes the gallbladder and other/unspecified parts of the biliary tract,

    Includes the lung and bronchus.

    Table 7. Trends in the 5-year relative survival rates (%) by year of diagnosis from 1993 to 2017 in Korea

    CNS, central nervous system.

    Absolute percentage change in 5-year relative survival from 1993 to 1995 and 2013 to 2017,

    Includes the liver and intrahepatic bile duct,

    Includes the gallbladder and other/unspecified parts of the biliary tract,

    Includes the lung and bronchus.

    Table 8. Crude and age-standardized rates of cancer prevalence by sex on January 1, 2018 in Korea

    CNS, central nervous system.

    Crude prevalence rate: number of prevalent cases divided by the corresponding person-years of observation. Prevalent cases were defined as patients who were diagnosed between January 1, 1999 and December 31, 2017, and who were alive on January 1, 2018. Multiple primary cancer cases were counted multiple times,

    Age-adjusted using Segi’s world standard population,

    Includes the liver and intrahepatic bile duct,

    Includes the gallbladder and other/unspecified parts of the biliary tract,

    Includes the lung and bronchus.

    Table 1.

    Table 2.

    Table 3.

    Table 4.

    Table 5.

    Table 6.

    Table 7.

    Table 8.

    Cancer Res Treat : Cancer Research and Treatment
    © Korean Cancer Association.
    Close layer
    TOP